Document And Entity Information
Document And Entity Information | 12 Months Ended |
Nov. 30, 2021shares | |
Entity Addresses [Line Items] | |
Entity Registrant Name | PLYMOUTH ROCK TECHNOLOGIES INC. |
Entity Central Index Key | 0001639142 |
Document Type | 20-F |
Document Period End Date | Nov. 30, 2021 |
Current Fiscal Year End Date | --11-30 |
Document Fiscal Period Focus | FY |
Document Fiscal Year Focus | 2021 |
Amendment Flag | false |
Document Registration Statement | false |
Document Annual Report | true |
Document Transition Report | false |
Entity Common Stock Shares Outstanding | 59,239,336 |
Entity Incorporation, State or Country Code | Z4 |
Entity Address, Address Line One | Suite 700 - 1199 West Hastings Street |
Entity Address, City or Town | Vancouver |
Entity Address, Country | CA |
Entity Address, State or Province | BC |
Entity Address, Postal Zip Code | V6E 3T5 |
Entity Well Known Seasoned Issuer | No |
Entity Current Reporting Status | No |
Entity Interactive Data Current | No |
Entity Filer Category | Non-accelerated Filer |
Entity Voluntary Filers | No |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Shell Company | false |
Document Accounting Standard | International Financial Reporting Standards |
Title of 12(b) Security | Common Stock |
Auditor Name | Manning Elliot LLP |
Auditor Location | Vancouver, British Columbia |
Auditor Firm ID | 1524 |
Business Contact [Member] | |
Entity Addresses [Line Items] | |
Contact Personnel Name | Dana Wheeler |
Entity Address, Address Line One | Suite 700 - 1199 West Hastings Street |
Entity Address, City or Town | Vancouver |
Entity Address, Country | CA |
Entity Address, State or Province | BC |
Entity Address, Postal Zip Code | V6E 3T5 |
Local Phone Number | 404-7685 |
City Area Code | 774 |
Consolidated Statements of Fina
Consolidated Statements of Financial Position - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Current assets | ||
Cash | $ 375,046 | $ 24,713 |
Accounts receivable | 11,848 | 2,786 |
Sales tax receivable | 56,237 | 4,317 |
Inventories | 11,086 | 19,695 |
Prepaid expenses | 178,321 | 25,908 |
Due from related parties | 0 | 2,500 |
Total current assets | 632,538 | 79,919 |
Non-current assets | ||
Equipment | 294,188 | 66,818 |
Right-of-use asset | 72,734 | 114,648 |
Intangible assets, net | 549,679 | 0 |
Total assets | 1,549,139 | 261,385 |
Current liabilities | ||
Accounts payable and accrued liabilities | 608,385 | 242,278 |
Lease liability | 39,221 | 34,105 |
Current portion of loans payable | 6,332 | 0 |
Due to related parties | 52,728 | 46,355 |
Total current liabilities | 706,666 | 322,738 |
Non-current liabilities | ||
Lease liability | 47,125 | 90,735 |
Loan payable | 22,545 | 0 |
Total liabilities | 776,336 | 413,473 |
SHAREHOLDERS' EQUITY (DEFICIENCY) | ||
Share capital | 11,834,582 | 7,376,763 |
Contributed surplus | 2,709,790 | 1,298,487 |
Accumulated other comprehensive income | 96,393 | 65,790 |
Deficit | (13,867,962) | (8,893,128) |
Total shareholders' equity (deficiency) | 772,803 | (152,088) |
Total liabilities and shareholders' equity | $ 1,549,139 | $ 261,385 |
Consolidated Statements of Loss
Consolidated Statements of Loss and Comprehensive Loss - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Income Statement | |||
Sales | $ 184,396 | $ 70,931 | $ 28,257 |
Cost of sales | 103,109 | 31,316 | 11,891 |
Gross Profit | 81,287 | 39,615 | 16,366 |
OPERATING EXPENSES | |||
General and administrative | 3,320,081 | 1,596,658 | 1,905,475 |
Selling | 709,010 | 1,081,478 | 739,615 |
Research and development | 985,006 | 386,044 | 399,720 |
Total expenses | 5,014,097 | 3,064,180 | 3,044,810 |
OTHER INCOME (EXPENSES) | |||
Written-off of inventories | 0 | 0 | (22,800) |
Impairment of development assets | 0 | 0 | (1,315,678) |
Impairment of goodwill | 0 | 0 | (256,874) |
Interest income | 0 | 193 | 14,226 |
Interest expense | 0 | (165) | (394) |
Paycheck protection program | 0 | 100,818 | 0 |
Foreign exchange loss | (42,024) | (517) | (2,322) |
NET LOSS BEFORE INCOME TAX | (4,974,834) | (2,924,236) | (4,612,286) |
Deferred income tax recovery | 0 | 0 | 245,479 |
NET LOSS | (4,974,834) | (2,924,236) | (4,366,807) |
OTHER COMPREHENSIVE INCOME | |||
Foreign currency translation gain | 30,603 | 19,546 | 46,244 |
TOTAL COMPREHENSIVE LOSS | $ (4,944,231) | $ (2,904,690) | $ (4,320,563) |
LOSS PER SHARE, basic and diluted | $ (0.09) | $ (0.08) | $ (0.14) |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, basic and diluted | 53,075,143 | 37,525,451 | 32,157,904 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Shareholders' Equity (Deficiency) - CAD ($) | Share capital [Member] | Shares to be issued [Member] | Contributed Surplus [Member] | Deficit [Member] | Accumulated other comprehensive losses [Member] | Total |
Beginning Balance at Nov. 30, 2018 | $ 5,311,034 | $ 185,024 | $ (1,602,085) | $ 3,893,973 | ||
Beginning Balance (Shares) at Nov. 30, 2018 | 31,761,300 | |||||
Statements Line Items | ||||||
Net loss for the year | (4,366,807) | (4,366,807) | ||||
Shares issued for warrants exercised | $ 187,120 | 187,120 | ||||
Shares issued for warrants exercised (Shares) | 910,300 | |||||
Shares issued for options exercised | $ 37,500 | 37,500 | ||||
Shares issued for options exercised (Shares) | 125,000 | |||||
Fair value of agent warrants exercised | $ 127,254 | (127,254) | ||||
Fair value of options exercised | 13,590 | (13,590) | ||||
Stock-based compensation | 692,091 | 692,091 | ||||
Shares to be issued | $ 22,811 | 22,811 | ||||
Foreign currency translation gain | $ 46,244 | 46,244 | ||||
Ending Balance at Nov. 30, 2019 | $ 5,676,498 | 22,811 | 736,271 | (5,968,892) | 46,244 | 512,932 |
Ending Balance (Shares) at Nov. 30, 2019 | 32,796,600 | |||||
Statements Line Items | ||||||
Net loss for the year | (2,924,236) | (2,924,236) | ||||
Shares issued for warrants exercised | $ 246,667 | 246,667 | ||||
Shares issued for warrants exercised (Shares) | 1,233,334 | |||||
Private placements | $ 1,367,325 | $ (22,811) | 83,109 | 1,427,623 | ||
Private placements (Shares) | 8,232,330 | |||||
Share issuance costs | $ (38,727) | (38,727) | ||||
Shares issued as compensation | $ 125,000 | 125,000 | ||||
Shares issued as compensation (Shares) | 500,000 | |||||
Stock-based compensation | 479,107 | 479,107 | ||||
Foreign currency translation gain | 19,546 | 19,546 | ||||
Ending Balance at Nov. 30, 2020 | $ 7,376,763 | 1,298,487 | (8,893,128) | 65,790 | (152,088) | |
Ending Balance (Shares) at Nov. 30, 2020 | 42,762,264 | |||||
Statements Line Items | ||||||
Net loss for the year | (4,974,834) | (4,974,834) | ||||
Shares issued for warrants exercised | $ 1,332,727 | 1,332,727 | ||||
Shares issued for warrants exercised (Shares) | 6,129,572 | |||||
Fair value of warrants exercised | $ 36,859 | (36,859) | ||||
Private placements | $ 2,749,000 | 287,499 | 3,036,499 | |||
Private placements (Shares) | 8,930,000 | |||||
Shares issued for options exercised | $ 222,500 | 222,500 | ||||
Shares issued for options exercised (Shares) | 425,000 | |||||
Fair value of options exercised | $ 158,106 | (158,106) | ||||
Fair value of broker warrants granted | (174,427) | 174,427 | ||||
Shares issued to finders | $ (100,500) | (100,500) | ||||
Shares issued to finders (Shares) | 336,250 | |||||
Cash paid to finders | $ 74,180 | (74,180) | ||||
Shares issued as compensation | $ 307,734 | 307,734 | ||||
Shares issued as compensation (Shares) | 656,250 | |||||
Stock-based compensation | 1,144,342 | 1,144,342 | ||||
Foreign currency translation gain | 30,603 | 30,603 | ||||
Ending Balance at Nov. 30, 2021 | $ 11,834,582 | $ 2,709,790 | $ (13,867,962) | $ 96,393 | $ 772,803 | |
Ending Balance (Shares) at Nov. 30, 2021 | 59,239,336 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Operating Activities | |||
Net loss for the year | $ (4,974,834) | $ (2,924,236) | $ (4,366,807) |
Items not affecting cash: | |||
Stock-based compensation | 1,144,342 | 479,107 | 692,091 |
Amortization expense | 143,783 | 41,201 | 1,717 |
Interest accretion | 14,760 | 20,449 | 0 |
Impairment of development assets | 0 | 3,576 | 1,286,094 |
Impairment of goodwill | 0 | 0 | 256,876 |
Write-off of inventory | 0 | 0 | 22,800 |
Interest expense | 0 | 0 | 394 |
Consulting fees | 307,734 | 125,000 | 0 |
Deferred income tax recovery | 0 | 0 | (245,479) |
Changes in non-cash working capital: | |||
Sales tax receivable | (51,583) | 2,993 | (1,324) |
Accounts receivable | (9,062) | (1,334) | (1,488) |
Inventories | 8,609 | (19,695) | 0 |
Prepaid expenses | (140,868) | 77,590 | (55,627) |
Due from related parties | 2,500 | (22,570) | (20,673) |
Due to related parties | (8,894) | 36,320 | 9,792 |
Accounts payable and accrued liabilities | 122,411 | 67,084 | 104,272 |
Net cash used in operating activities | (3,441,102) | (2,114,515) | (2,317,362) |
Investing Activities | |||
Purchase of equipment | (204,305) | (57,518) | (14,175) |
Acquisition of Tetra, net of cash deficiency | (369,038) | 0 | 0 |
Development expenses | 0 | (3,576) | 0 |
Net cash used in investing activities | (573,343) | (61,094) | (14,175) |
Financing Activities | |||
Common shares issued for cash, net of share issuance costs | 4,417,047 | 1,635,564 | 224,619 |
Lease payments | (48,175) | (48,473) | 0 |
Repayment of loan payable | (42,430) | 0 | (52,256) |
Net cash provided by financing activities | 4,326,442 | 1,587,091 | 172,363 |
Increase (decrease) in cash | 311,997 | (588,518) | (2,159,174) |
Effect of foreign exchange rate changes on cash | 38,336 | 30,112 | (1,401) |
Cash, beginning of the year | 24,713 | 583,119 | 2,743,694 |
Cash, end of the year | $ 375,046 | $ 24,713 | $ 583,119 |
NATURE OF OPERATIONS AND ABILIT
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN | 12 Months Ended |
Nov. 30, 2021 | |
Nature Of Operations And Ability To Continue As Going Concern Abstract | |
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN [Text Block] | 1. Plymouth Rock Technologies Inc. (the "Company") was incorporated under the Business Corporations Act of British Columbia on October 17, 2011. The head office, principal address and registered and records office of the Company are located at 206 - 1045 West 8 th On March 10, 2016, the Company's common shares commenced trading on the CSE. On January 8, 2019, the Company's common shares commenced trading on the Frankfurt Stock Exchange in Germany under the Symbol: 4XA, WKN# - A2N8RH. Effective August 27, 2019, the Company's common shares commenced trading on the OTC Markets Group ("OTCQB") under the symbol: PLRTF. Since the Company completed its business acquisition with Plymouth Rock Technologies Inc. ("Plymouth Rock USA") in 2018, it has changed its name from Alexandra Capital Corp. to Plymouth Rock Technologies Inc. with the trading symbol "PRT" on November 1, 2018. As a result of the acquisition, the Company's principal business activity through its subsidiary, Plymouth Rock USA ("PRT USA"), was changed to focus on developing technologies related to remotely detecting assault firearms and suicide bombs concealed on the person or a carry bag. The Company focuses on detection methods with and without the need for a checkpoint of the suspect who is being screened. The Company's planned products encompass the very latest radar, imaging, and Unmanned Aerial System ("UAS") technologies for quickly detecting, locating and identifying the presence of threats and for search and rescue missions for law enforcement. On March 26, 2021, the Company incorporated a subsidiary in United Kingdom, Plymouth Rock Technologies UK Limited ("PRT UK"). The purpose of PRT UK is to augment the Company's existing research and development of its drone technologies for the US and EMEA markets. On June 4, 2021, the Company completed its acquisition of Tetra Drones Limited ("Tetra") (Note 3). The acquisition of Tetra provides the Company with drones production line in the United Kingdom. Going Concern These consolidated financial statements are prepared on a going concern basis, which contemplates that the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. At present, the Company's operations do not generate cash flows from operations. The Company has incurred losses since inception and has a comprehensive loss of $4,944,231 for the year ended November 30, 2021, (2020 - $2,904,690) and had an accumulated deficit of $13,867,962 (2020 - $8,893,128). The ability of the Company to continue as a going concern is dependent on achieving profitable operations, commercializing its technologies, and obtaining the necessary financing in order to develop these technologies further. The outcome of these matters cannot be predicted at this time. The Company will continue to review the prospects of raising additional debt and equity financing to support its operations until such time that its operations become self- sustaining, to fund its research and development activities and to ensure the realization of its assets and discharge of its liabilities. While the Company is expending its best efforts to achieve the above plans, there is no assurance that any such activity will generate sufficient funds for future operations. These factors and uncertainty casts significant doubt about the Company's ability to continue as a going concern and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business. The Company is not expected to be profitable during the ensuing 12 months, and therefore, must rely on securing additional funds from either issuance of debt or equity financing for cash consideration. During the year ended November 30, 2021, the Company received net cash proceeds of $4,417,047 (November 30, 2020 - $1,635,564) pursuant to financing activities. Management has been successful in raising capital through periodic private placements of the Company's common shares in the past, however there is no certainty that financing will be available in the future, or certainty that management's planned actions to address this situation will be successful. These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future rather than a process of forced liquidation. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence. Such adjustments could be material. In March 2020, the World Health Organization declared a global pandemic known as COVID-19. The expected impacts on global commerce are expected to be far reaching. Material uncertainties may come into existence that could influence management's going concern assumption. The duration and impact of the COVID-19 outbreak is currently unknown and it is not possible to reliably estimate the length and severity of these developments and the impact on the financial results and condition of the Company and its subsidiaries, in future periods, such as: • This will and has impacted demand and testing for the Company's products and services in the near term and will and has impacted the Company's supply chains. • It may and has also impacted the availability of external funding sources during this year. • the effect on labor availability due to the severity and the length of potential measures taken by governments to manage the spread of the disease. Management continues to closely evaluate the impact of COVID-19 on the Company's business. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Significant Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES [Text Block] | 2. SIGNIFICANT ACCOUNTING POLICIES Basis of presentation These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). These Financial Statements are authorized for issue by the Board of Directors on May 2, 2022. These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting. These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income. Significant accounting judgments, estimates and assumptions The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates. Significant judgements and estimates used in preparing the Financial Statements include, but are not limited to the following: (i) The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation. (ii) The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate. (iii) Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. At November 30, 2019, Management was unable to project cash flows that can be generated from its CGUs and consequently, the intangible assets acquired and the goodwill generated from a previously completed business acquisition were determined to be impaired, therefore an impairment loss of $1,572,552 was charged for the 2019 year end. No impairment loss was recorded during the years ended November 30, 2020 and 2021. Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following: (i) Going concern Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2021. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so. In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, 12 months from the end of the reporting period. (ii) Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 was an asset acquisition. (iii) Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2021, the Company has customer relationships reported as intangible assets that are being amortized over a period of three years from date of acquisition. Cash Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk. Consolidation The Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiaries are presented in the table below. PRT USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. PRT UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021 and Tetra was acquired on June 4, 2021. Entity Country of incorporation Effective economic interest PRT USA United States of America 100% PRT UK United Kingdom 100% Tetra United Kingdom 100% Intangible assets Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations or assets acquisition. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired. Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met: • technical feasibility can be demonstrated; • management has the intention to complete the intangible asset and use it; • management can demonstrate the ability to use the intangible asset; • it is probable that the intangible asset will generate future economic benefits; • the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and • costs attributable to the asset can be measured reliably. The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred. Intangible assets with finite life are amortized over the estimated useful lives. Equipment Recognition and measurement On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions. Equipment is subsequently measured at cost less accumulated amortization, less any accumulated impairment losses. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment. Gains and losses Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss. Amortization Half of the normal amortization is taken in the year of acquisition for equipment with declining balance method. The amortization rates applicable to each category of property and equipment are as follows: Computer equipment Furniture Vehicles Inventories The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition. Business combinations Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition related costs are recognized in profit or loss as incurred. The excess of the consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment. Share capital The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve. Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued. Stock-based compensation The Company recognizes stock-based compensation expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, contributed surplus will be reduced by the applicable amount. Stock-based compensation Share-based payment calculations have no effect in the Company's cash position. Earnings (loss) per share Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive. Financial instruments Financial assets The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred. Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties. The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated. The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions. The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime. Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof. The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire. Financial liabilities The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss. Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, loans payable and due to related parties. The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire. Interest Interest income and expense are recognized in profit or loss using the effective interest method. The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets. The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses. Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability. Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis. Offsetting Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously. Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material. Revenue recognition Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered. Government Grants Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan. Income taxes Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date. A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis. Related party transactions Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Leases The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease. In accordance with the transition of IFRS 16, the Company recognized a right-of-use asset and lease liability of $152,864 at the adoption date. When measuring lease liabilities, the Company's incremental borrowing rate applied was 15% per annum. New IFRS standards that are effective for the current year In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or an asset acquisition. The amendments provide an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company adopted this amendment on December 1, 2020 and has determined that there has been no material impact to the Company's consolidated financial statements. Accounting standards, amendments and interpretations not yet effective Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the year but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below. IAS 1 - Classification of Liabilities as Current or Noncurrent IAS 16 - Proceeds before Intended Use These new and amended standards are not expected to have a material impact on the Company's consolidated financial statements. |
ACQUISITION
ACQUISITION | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of detailed information about business combination [abstract] | |
ACQUISITON [Text Block] | 3. ACQUISITION On June 4, 2021, the Company acquired the 100% issued and outstanding ordinary shares of Tetra from two arm's length parties for £350,000. Tetra was a privately held UK-based company which develops custom-made, Unmanned Aircraft Systems ("UAS"). The consideration of £350,000 ($579,682) is payable as follows: 1) 2) 3) 4) The Company applied the optional concentration test permitted under IFRS 3 to the acquisition which resulted in the acquired assets being accounted for as an asset acquisition. As such the purchase price was allocated to the identifiable assets and liabilities based on their fair values at the date of acquisition. The allocation of the consideration for the purposes of the consolidated statements of financial position is as follows: Total Consideration Cash $ 579,682 Net assets acquired (liabilities assumed) Cash indebtedness $ (12,127 ) Equipment 27,799 Prepaid expenses 11,131 Due to a related party (13,699 ) Bank loan (40,447 ) Accounts payable (19,210 ) Vehicle loan (30,859 ) Net assets acquired (liabilities assumed) $ (77,412 ) Purchase price allocation Net identifiable assets acquired $ (77,412 ) Customer relationships 657,094 $ 579,682 |
PREPAID EXPENSES
PREPAID EXPENSES | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Detail Information About Prepaid Expenses [Abstract] | |
PREPAID EXPENSES [Text Block] | 4. PREPAID EXPENSES As at November 30, 2021 and 2020, the Company's prepaid expenses consist of the following: November 30, 2021 November 30, 2020 Advertising and promotions $ 127,664 $ 9,494 Rent 11,211 10,993 Other 39,446 5,421 $ 178,321 $ 25,908 As at November 30, 2021, other includes $5,513 in prepayment to related parties (November 30, 2020 - $4,000) (Note 8). |
EQUIPMENT
EQUIPMENT | 12 Months Ended |
Nov. 30, 2021 | |
Property, plant and equipment [abstract] | |
EQUIPMENT [Text Block] | 5. EQUIPMENT Computer Furniture Vehicles Leasehold Demo Total $ $ $ $ $ $ Cost: Balance at November 30, 2019 1,726 12,455 - - - 14,181 Additions - - - - 61,162 61,162 Foreign currency translation adjustment (42 ) (304 ) - - (3,644 ) (3,990 ) Balance at November 30, 2020 1,684 12,151 - - 57,518 71,353 Additions (Note 3) 22,664 7,244 16,243 3,881 184,484 234,516 Foreign currency translation adjustment (320 ) (124 ) (229 ) (55 ) (2,255 ) (2,983 ) Balance at November 30, 2021 24,028 19,271 16,014 3,826 239,747 302,886 Accumulated Depreciation: Balance at November 30, 2019 473 1,244 - - - 1,717 Amortization 702 2,283 - - - 2,985 Foreign currency translation adjustment (41 ) (126 ) - - - (167 ) Balance at November 30, 2020 1,134 3,401 - - - 4,535 Amortization 561 2,055 1,201 287 - 4,104 Foreign currency translation adjustment 21 17 17 4 - 59 Balance at November 30, 2021 1,716 5,473 1,218 291 - 8,698 Net Book Value: At November 30, 2020 550 8,750 - - 57,518 66,818 At November 30, 2021 22,312 13,798 14,796 3,535 239,747 294,188 As at November 30, 2021, the demo equipment is under construction and thus it is not available for use. As a result, there was no amortization taken on the equipment. |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 12 Months Ended |
Nov. 30, 2021 | |
Intangible assets and goodwill [abstract] | |
INTANGIBLE ASSETS [Text Block] | 6. INTANGIBLE ASSETS During the year ended November 30, 2021, the Company acquired Tetra, see Note 3. Included in the acquisition is the identifiable intangible asset, customer relationships valued at $657,094. The intangible asset is being amortized over its estimated useful life of 3 years. Previously, the Company's intangible assets were composed of the assets acquired from the acquisition of Plymouth Rock USA. The Company is in the process of developing and commercializing the following intangible assets: (1) A Millimeter Remote Imaging from Airborne Drone ("Drone X1 System"); (2) A compact microwave radar system for scanning shoe's ("Shoe-Scanner"); and (3) Wi-Fi radar techniques for threat detection screening in Wi-Fi enabled zones in buildings and places, such as airports, shopping malls, schools and sports venues ("Wi-Ti"). These assets can remotely detect, locate and identify the presence of threats. Cost: Customer Drone X1 Shoe- Scanner Wi-Ti Total Balance at November 30, 2018 $ - $ 868,547 $ - $ 372,234 $ 1,240,781 Additions - - 30,000 - 30,000 Impairment - (900,260 ) (29,592 ) (385,826 ) (1,315,678 ) Foreign currency translation adjustment - 31,713 (408 ) 13,592 44,897 Balance at November 30, 2019 and 2020 - - - - - Additions 657,094 - - - 657,094 Balance at November 30, 2021 657,094 - - - 657,094 Accumulated amortization: Balance at November 2018, 2019 and 2020 - - - - - - Amortization (107,415 ) - - - (107,415 ) (107,415 ) - - - (107,415 ) Net book value Balance at November 30, 2020 and 2019- - - - - Balance at November 30, 2021 $ 549,679 $ - $ - $ - $ 549,679 For impairment testing purpose, the Company identified that each intangible asset is a separate cash- generating unit ("CGU'). Management was unable to project cash flows that could be generated from each of the CGUs, and consequently an impairment loss to write-down the carrying amounts to $nil was recognized during the year ended November 30, 2019. During the year ended November 30, 2019, the development costs of $399,720 were expensed as management was unable to demonstrate the future economic benefits to be generated from the utilization of the assets. |
ACCOUNTS PAYABLE
ACCOUNTS PAYABLE | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Detail Information About Accounts Payable [Abstract] | |
ACCOUNTS PAYABLE [Text Block] | 7. ACCOUNTS PAYABLE As at November 30, 2021 and 2020, the Company's accounts payable consist of the following: November 30, 2021 November 30, 2020 Professional fees $ 92,078 $ 74,178 Funds to be returned to investors 43,046 43,046 Advertising costs 42,241 5,164 Due to former shareholder of Tetra 222,771 - Payroll 33,173 - Development costs 123,334 77,675 Others 51,742 42,215 $ 608,385 $ 242,278 As at November 30, 2021, an amount of £140,000 ($222,771) (November 30, 2020 - $ Nil |
RELATED PARTY TRANSACTIONS AND
RELATED PARTY TRANSACTIONS AND BALANCES | 12 Months Ended |
Nov. 30, 2021 | |
Related party transactions [abstract] | |
RELATED PARTY TRANSACTIONS AND BALANCES [Text Block] | 8. RELATED PARTY TRANSACTIONS AND BALANCES Key management compensation The amounts due to and from related parties are due to the directors and officers of the Company. The balances are unsecured, non-interest bearing and due on demand. These transactions are in the normal course of operations and have been valued in these consolidated financial statements at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Key management is comprised of directors and officers of the Company. As at November 30, 2021, $Nil (November 30, 2020 - $2,500) was due from directors and officers of the Company. As at November 30, 2021, $52,728 (November 30, 2020 - $46,355) was due to directors and officers of the Company as follows: November 30, 2021 November 30, 2020 Company controlled by Former Chief Financial Officer $ - $ 3,865 Company controlled by Corporate Secretary 10,500 - Chief Executive Officer of the Company 561 823 Director 41,667 41,667 $ 52,728 $ 46,355 As at November 30, 2021, prepaid expenses include prepayments of $5,513 (November 30, 2020 - $4,000) to a company controlled by the corporate secretary. During the years ended November 30, 2021, 2020 and 2019, the Company entered into the following transactions with related parties: November 30, 2021 November 30, 2020 November 30, 2019 Management fees $ 118,000 $ 114,125 $ 123,000 Consulting fees 307,734 166,667 - Accounting fees 36,202 22,852 24,490 Rent 5,000 20,000 - Stock-based compensation 410,132 271,993 260,145 Salaries and benefits to CEO 313,626 133,387 318,790 $ 1,190,694 $ 729,024 $ 726,425 Management fees consisted of the following: November 30, 2021 November 30, 2020 November 30, 2019 Company controlled by Interim CFO and Corporate Secretary $ 63,000 $ 55,125 $ 63,000 Company controlled by Former CFO 55,000 59,000 60,000 $ 118,000 $ 114,125 $ 123,000 During the year ended November 30, 2021, the Company issued 656,250 (2020 - 500,000 and 2019 - nil) common shares valued at $307,734 (2020 - $166,667 and 2019 - $nil) to a director of the Company for consulting services (Note 12). During the year ended November 30, 2021, accounting fees of $36,202 (2020 - $22,852 and 2019 - $24,490) and rent of $5,000 (2020 - $20,000 and 2019 - $nil) were paid or accrued to a Company controlled by the Former CFO. During the year ended November 30, 2021, the Company had 1,725,000 stock options held by the CEO, Former CFO, the Corporate Secretary, and the Company's directors. The amount recognized as expense for these options for the year ended November 30, 2021 is as follows: November 30, 2021 November 30, 2020 November 30, 2019 Number of Expense for the Number of Expense for Number of Expense for CEO 600,000 $ 133,275 400,000 $ 44,455 400,000 $ 113,077 Former CFO 150,000 33,319 100,000 11,113 100,000 28,269 Corporate Secretary 150,000 33,319 100,000 11,113 100,000 28,269 Directors 825,000 210,219 1,050,000 205,312 250,000 90,530 1,725,000 $ 410,132 1,650,000 $ 271,993 850,000 $ 260,145 |
GOVERMENT ASSISTANCE RECEIVED
GOVERMENT ASSISTANCE RECEIVED | 12 Months Ended |
Nov. 30, 2021 | |
Government Assistance Received [Abstract] | |
GOVERNMENT ASSISTANCE RECEIVED [Text Block] | 9. GOVERMENT ASSISTANCE RECEIVED On May 4, 2020, the Company received a CARES Act Paycheck Protection Program Loan ("PPP Loan") of US$75,000 ($100,818). The PPP Loan bore interest at 1% per annum and was repayable monthly staring on December 4, 2020. During the year ended November 30, 2020 , the PPA Loan was forgiven as the Company met the requirements and as a result, the amount of $100,818 was treated as a government grant and was offset against operating expenses on the consolidated statements of loss and comprehensive loss. |
LOAN PAYABLE
LOAN PAYABLE | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of detailed information about borrowings [abstract] | |
LOAN PAYABLE [Text Block] | 10. LOAN PAYABLE As at November 30, 2021, the Company assumed the loan payable related to the vehicle acquired from Tetra as described in note 3. The interest rate and maturity date are as follows: Principal Principal Interest Commencement Maturity Balance, 2021 Vehicle £ 13,000 $ 30,859 6.95% May 2, 2019 June 2, 2024 $ 28,877 The vehicle is collateral for the loan. In the event of default in payments, the interest is increased to 13.9% on the overdue amount. As at November 30, 2021, an amount of $6,332 represents the repayment of loan payable for the next 12 months period. |
CAPITAL MANAGEMENT
CAPITAL MANAGEMENT | 12 Months Ended |
Nov. 30, 2021 | |
Capital Management [Abstract] | |
CAPITAL MANAGEMENT [Text Block] | 11. CAPITAL MANAGEMENT The Company considers its capital structure to include net residual equity of all assets, less liabilities. The Company's objectives when managing capital are to (i) maintain financial flexibility in order to preserve its ability to meet financial obligations and continue as a going concern; (ii) maintain a capital structure that allows the Company to pursue the development of its projects and products; and (iii) optimize the use of its capital to provide an appropriate investment return to its shareholders commensurate with risk. The Company's financial strategy is formulated and adapted according to market conditions in order to maintain a flexible capital structure that is consistent with its objectives and the risk characteristics of its underlying assets. The Company manages its capital structure and adjusts it in light of changes in economic conditions and the risk characteristics of its underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares or acquire or dispose of assets. |
SHARE CAPITAL
SHARE CAPITAL | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of classes of share capital [abstract] | |
SHARE CAPITAL [Text Block] | 12. SHARE CAPITAL (a) Authorized: Unlimited number of common shares without par value As at November 30, 2021, there were 59,239,336 common shares issued and outstanding (November 30, 2020 - 42,762,264). As at November 30, 2021, the Company has Nil common shares (2020 - 607,500) held in escrow. During the year ended November 30, 2021 On January 29, 2021, the Company issued 3,180,000 Units at $0.20 per unit for proceeds of $636,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.25 for five years. The Company paid cash of $10,480, issued 170,000 finders' Units with a fair value of $34,000 and 222,400 broker warrants as finder's fees . Each finder's Unit comprised of one common share and one full non-transferable common share purchase warrant with exercise price of $0.25 per share for five years. The broker warrants are exercisable at $0.25 per share for five years. On August 9, 2021, the Company issued 5,750,000 Units at $0.40 per unit for proceeds of $2,300,000. Each unit comprised one common share and one full non-transferable common share purchase warrant, with each warrant entitling the holder to purchase one additional common share at a price of $0.50 for five years. The Company paid cash of $63,700, issued 166,250 finders' Units with a fair value of $66,500 and 325,750 broker warrants as finder's fees. Each finders' Unit comprised of one common share and one full non-transferable common share purchase warrant, with exercise price of $0.50 per share for five years. The broker warrants are exercisable at $0.50 per share for five years. During the year ended November 30, 2021, the Company issued 425,000 common shares for gross proceeds of $222,500 from the exercise of 425,000 stock options at $0.50 to $0.60 per share. During the year ended November 30, 2021, the Company issued 6,129,572 common shares for gross proceeds of $1,332,727 from the exercise of 6,129,572 share purchase warrants at $0.20 to $0.50 per share . During the year ended November 30, 2021, the Company issued 656,250 common shares with total fair value of $307,734 were issued as compensation for consulting fees to a director (note 8). During the year ended November 30, 2020 On September 30, 2020, the Company issued 50,000 common shares pursuant to the exercise of 50,000 share purchase warrants at $0.20 per share. On September 30, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a director (Note 8) valued at a total of $62,500. On September 30, 2020, the Company issued an aggregate of 1,335,165 units at a price of CDN$0.30 per unit for gross proceeds of $400,550. Each Unit consists of one common share and one-half of one non- transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $40,055. On September 30, 2020, the Company issued 50,000 units at a fair value of $22,811 pursuant to the binding agreement with Aerowave Corporation. Each Unit consists of one common share and one-half of one non- transferable common share purchase warrant (a "Warrant"). Each whole Warrant entitles the holder to purchase one additional common share at a price of $0.50 for two years until September 30, 2022. The fair value of the warrants is determined to be $1,500. On September 24, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share. On September 22, 2020, the Company issued 100,000 common shares pursuant to the exercise of 100,000 share purchase warrants at $0.20 per share. On August 21, 2020, the Company issued 250,000 common shares were issued as compensation for consulting fees to a Director (Note 8) valued at a total of $62,500. On August 13, 2020, the Company issued 483,334 common shares pursuant to the exercise of 483,334 share purchase warrants at $0.20 per share. On July 3, 2020, the Company issued 500,000 common shares pursuant to the exercise of 500,000 share purchase warrants at $0.20 per share. On May 15, 2020, the Company issued an aggregate of 3,718,831 units at a price of $0.15 per unit for gross proceeds of $557,825. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022. On April 24, 2020, the Company issued an aggregate of 3,128,334 units at a price of $0.15 per unit for gross proceeds of $469,250. Each unit consists of one common share in the capital of the Company and one whole transferable common share purchase warrant (a "Warrant"). Each whole Warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022. In connection with the April 24, 2020 and May 15, 2020 private placements, the Company paid $38,727 in share issuance costs. On February 4, 2020, the Company arranged a non-brokered private placement financing of up to 10,000,000 units of securities at a price of $0.40 per unit for aggregate gross proceeds of up to $4,000,000 (the "Offering"). Each unit will be comprised of one common share and one-half of one non- transferable common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share at a price of $0.80 for two years from closing of the Offering. On March 16, 2020, due to the instability in the financial markets caused by the COVID-19 pandemic, the Company cancelled this private placement. And paid $4,400 to investors in connection with this cancelled private placement. During the year ended November 30, 2019 During the year ended November 30, 2019, the Company issued a total of 910,300 common shares for gross proceeds of $187,120 for 7,500 warrants exercised at a price of $0.60 per share, 307,800 warrants exercised at a price of $0.40 per share and 595,000 warrants exercised at a price of $0.10 per share. The Company also issued a total of 125,000 common shares for gross proceeds of $37,500 for 125,000 options exercised at a price of $0.30 per share. (b) On November 12, 2014 the Company adopted an incentive stock option plan (the "Option Plan") which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees, and consultants to the Company, non-transferable options to purchase common shares, provided that the number of common shares reserved for issuance will not exceed 10% of the issued and outstanding common shares in the capital of the Company at the time of granting of options. During the year ended November 30, 2021 On January 21, 2021, the Company granted 1,550,000 incentive stock options to directors, consultants, and employees, options vested on grant date and with an exercise price of $0.75 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.75, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was estimated to be $1,022,995 and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021. On June 10, 2021, the Company granted 150,000 incentive stock options to a consultant, options vested on grant date and with an exercise price of $0.50 per share for a period of five years from the date of grant. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.485, volatility 100%, risk-free rate 0.82%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $53,682 and the amount was recognized on the consolidated statements of loss and comprehensive loss for the year ended November 30, 2021. The Company also recorded $67,665 stock-based compensation related to prior years' stock options that were vested in the year. For the year ended November 30, 2021, the Company recorded an aggregate amount of $1,144,342 (November 30, 2020 - $479,107 and 2019 - $692,091) as stock-based compensation on the consolidated statements of loss and comprehensive loss. During the year ended November 30, 2020 During the year ended November 30, 2020, 200,000 (2019 - 150,000) options issued to a director and a consultant were cancelled before vesting. During the year ended November 30, 2019 On January 16, 2019, the Company granted 2,300,000 stock options, which are exercisable for a period of five years, at a price of $0.60 per share. During the year, 150,000 of these stock options were cancelled. The remaining 2,150,000 stock options vest as follows: (i) 1,075,000 options on January 15, 2020, (ii) 268,750 options on April 15, 2020, (iii) 268,750 options on July 15, 2020, (iv) 268,750 options on October 15, 2020, and (v) 268,750 options on January 15, 2021. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.54, volatility 100%, risk-free rate 1.93%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $913,140, which will be expensed over the vesting period. On March 21, 2019, the Company granted an aggregate of 350,000 incentive stock options to consultants of the Company with an exercise price of $0.60 per share for a period of five years from the date of grant. The stock options vest as follows: (i) 175,000 options on March 20, 2020, (ii) 43,750 options on June 20, 2020, (iii) 43,750 options on December 20, 2020, (iv) 43,750 options on March 20, 2021, and (v) 43,750 options on June 20, 2021. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.57, volatility 100%, risk-free rate 1.56%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $147,613, which will be expensed over the vesting period. On November 29, 2019, the Company granted an aggregate of 650,000 incentive stock options to consultants and a director of the Company with an exercise price of $0.50 per share for a period of five years from the date of grant. The stock options vest as follows: (i) 325,000 options on November 30, 2020 and (ii) 325,000 options on November 30, 2021. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.49, volatility 100%, risk-free rate 1.49%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $236,809, which will be expensed over the vesting period. Stock option transactions and the number of stock options outstanding as at November 30, 2021, 2020 and 2019 are summarized as follows: Number of Options Weighted Average Exercise Price Balance, November 30, 2019 3,150,000 $ 0.30 Cancelled (200,000 ) 0.60 Balance, November 30, 2020 2,950,000 0.58 Granted 1,700,000 0.73 Exercised (425,000 ) 0.52 Balance, November 30, 2021 4,225,000 $ 0.65 The following summarizes the stock options outstanding at November 30, 2021: Weighted average Weighted Exercise Numbers of options Numbers of options remaining average Expiry Date Price outstanding exercisable life (year) price $ $ January 15, 2024 0.60 2,050,000 2,050,000 1.03 0.29 March 20, 2024 0.60 150,000 150,000 0.08 0.02 November 28, 2024 0.50 325,000 325,000 0.23 0.04 January 21, 2026 0.75 1,550,000 1,550,000 1.52 0.28 June 10, 2026 0.50 150,000 150,000 0.16 0.02 4,225,000 4,225,000 3.02 0.65 (c) During the year ended November 30, 2021 On August 9, 2021, the Company issued 5,916,250 common share purchase warrants as part of the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. On August 9, 2021, the Company also issued 325,750 warrants as finder's warrants as described in note 12(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until August 9, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.35, volatility 100%, risk-free rate 0.88%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $79,032. On January 29, 2021, the Company issued 3,350,000 common share purchase warrants as part of the private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.25 per share until January 29, 2026. On January 29, 2021, the Company also issued 222,400 warrants as finder's warrants as described in note 8(a) in connection with the private placement. Each warrant is exercisable to purchase one common share at an exercise price of $0.50 per share until January 29, 2026. The fair value was estimated using the Black-Scholes pricing model with estimated, stock price of $0.52, volatility 100%, risk-free rate 0.43%, dividend yield 0%, and expected life of 5 years. With these assumptions, the fair value of options was determined to be $95,395. During the year ended November 30, 2020 On September 30, 2020, the Company granted 692,583 common share purchase warrants as part of a non-brokered private placement and binding agreement with Aerowave Corporation. Each warrant is exercisable to acquire one common share at an exercise price of $0.50 per share until September 30, 2022. On May 15, 2020, the Company granted 3,718,831 common share purchase warrants as part of a non- brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until May 15, 2022. On April 24, 2020, the Company granted 3,128,334 common share purchase warrants as part of a non- brokered private placement. Each warrant is exercisable to acquire one common share at an exercise price of $0.20 per share until April 24, 2022. Share purchase warrant transactions and the number of share purchase warrants outstanding as at November 30, 2021, 2020 and 2019 are summarized as follows: Number of Warrants Weighted Average Exercise Price Balance, November 30, 2019 - $ - Warrants granted 7,539,748 0.90 Warrants exercised (1,233,334 ) 0.11 Balance, November 30, 2020 6,306,414 0.23 Warrants granted 9,814,400 0.08 Warrants exercised (6,129,572 ) 0.01 Balance, November 30, 2021 9,991,242 $ 0.41 The following summarizes the stock warrants outstanding at November 30, 2021: Expiry Date Exercise Price Number of Warrants Weighted average remaining Weighted average $ $ May 15, 2022 0.20 160,500 0.01 0.00 September 30, 2022 0.50 400,582 0.03 0.02 January 29, 2026 0.25 3,188,160 1.33 0.08 August 9, 2026 0.50 6,242,000 2.93 0.31 9,991,242 4.30 0.41 |
FINANCIAL RISK MANAGEMENT
FINANCIAL RISK MANAGEMENT | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Financial Risk Management Explanatory [Abstract] | |
FINANCIAL RISK MANAGEMENT [Text Block] | 13. FINANCIAL RISK MANAGEMENT The Company's financial assets consist of cash, accounts receivable and due from related parties. The estimated fair values of cash, accounts receivable, and due from related parties approximate their respective carrying values due to the short period to maturity. Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are: a. Level 1 - unadjusted quoted prices in active markets for identical assets or liabilities; b. Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and c. Level 3 - inputs that are not based on observable market data. For the years ended November 30, 2021 and 2020, the fair values of the cash, accounts receivable, accounts payable, and amounts due to and from related parties, and loan payable approximate the book value due to the short-term nature. The Company is exposed to a variety of financial instrument related risks. The Board approves and monitors the risk management processes, inclusive of counterparty limits, controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows: Liquidity Risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations when they become due. The Company ensures, as far as reasonably possible, it will have sufficient capital in order to meet short- term business requirements, after taking into account cash flows from operations and the Company's holdings of cash. The Company believes that these sources will be sufficient to cover the likely short-term cash requirements. The Company's cash is currently invested in business accounts which is available on demand by the Company for its operations. Interest Rate Risk Interest rate risk is the risk that future cash flows will fluctuate as a result of changes in market interest rates. The Company has no significant interest rate risk due to the short-term nature of its interest generating assets. Credit Risk Credit risk is the risk of a loss when a counterparty to a financial instrument fails to meet its contractual obligations. The Company's exposure to credit risk is limited to its cash. The Company limits its exposure to credit risk by holding its cash in deposits with high credit quality financial institutions in Canada, USA and United Kingdom. Foreign Currency Risk The Company is exposed to foreign currency risk on fluctuations related to cash, accounts receivable, leases, amounts due to and from related parties, and accounts payable that are denominated in US dollars and British Pound Sterling. A 10% fluctuations in the US dollar and British Pound Sterling against the Canadian dollar have affected comprehensive loss for the year by approximately $1,200 (2020 - $7,085 and 2019 - $1,100). |
SUPPLEMENTAL CASH FLOW INFORMAT
SUPPLEMENTAL CASH FLOW INFORMATION | 12 Months Ended |
Nov. 30, 2021 | |
Supplemental Cash Flows Information Abstract | |
SUPPLEMENTAL CASH FLOW INFORMATION [Text Block] | 14. SUPPLEMENTAL CASH FLOW INFORMATION During the years ended November 30, 2021, 2020 and 2019, the Company has the following non-cash investing and financing activities: November 30, 2021 $ November 30, November 30, Non-cash financing activities: Fair value of options granted and vested 1,144,342 479,107 - Fair value of options exercised 158,106 - 13,590 Fair value of options cancelled and expired - - 59,553 Fair value of warrants granted 174,427 83,109 127,254 Fair value of warrants exercised 36,859 - - Shares issued for finders 100,500 - - Shares issued for options exercised - - 37,500 Shares issued for warrants exercised - - 187,120 Non-cash investing activities: Shares to be issued for acquisition of inventory - - 22,800 Shares issued for consulting services 307,734 125,000 - |
COMMITMENTS
COMMITMENTS | 12 Months Ended |
Nov. 30, 2021 | |
Commitments [Abstract] | |
COMMITMENTS [Text Block] | 15. COMMITMENTS As at November 30, 2021, the Company has the following commitments: The Company signed a consulting agreement with an unrelated party whereby the consultant will assist the expansion of the Company's network in Europe. The agreement commenced in October 2021 for a period of 12 months with a monthly fee of $90,000. PRT UK has a license fee agreement whereby it will lease a parcel of land for an annual fee of £1,500 until April 30, 2024. PRT USA has a warehouse lease until June 3, 2022 with a monthly fee of US$1,500. In November 2018, PRT USA entered into two-year lease agreement for leased premises (Note 16) in Plymouth, Massachusetts, commenced December 1, 2018 and ended on November 30, 2020. On December 31, 2020, the Company renewed this lease agreement to November 30, 2023. The minimum base rent for the remaining lease term are: US$3,188 per month from December 1, 2021 to November 30, 2022; and US$3,284 per month from December 1, 2022 to November 30, 2023 (Note 16). On April 1, 2020 the Company entered into an agreement with a Director of the Company to provide consulting services. In line with this, the Company shall pay $250,000 annually either through cash in 12 monthly installments at the end of each calendar month or through the issuance of such number of common shares of the Company of equal value in four equal quarterly installments, in arrears (Note 8). The Company has certain commitments related to key management compensation for approximately $35,875 per month with no specific expiry of terms (Note 8). |
RIGHT-OF-USE ASSETS AND LEASE L
RIGHT-OF-USE ASSETS AND LEASE LIABILITY | 12 Months Ended |
Nov. 30, 2021 | |
Right Of Use Assets And Lease Liability [Abstract] | |
RIGHT-OF-USE ASSETS AND LEASE LIABILITY [Text Block] | 16. RIGHT-OF-USE ASSETS AND LEASE LIABILITY Right-of-use Assets The following is the continuity of the cost and accumulated depreciation of right-of-use assets, for the year ended November 30, 2021 and for the year ended November 30, 2020: Opening balance, December 1, 2019 $ - Recognition upon adoption of IFRS 16 152,864 Amortization expense (38,216 ) Balance, November 30, 2020 114,648 Amortization expense (35,654 ) Cumulative translation adjustment (6,260 ) Balance, November 30, 2021 $ 72,734 During the year ended November 30, 2020, the Company recognized right-of-use assets and corresponding lease liabilities upon the adoption of IFRS 16 related to its Massachusetts premises under lease (Note 15). The right-of-use assets are depreciated on a straight-line basis over the terms of the underlying lease agreements. Lease liability The following is the continuity of lease liability, for the years ended November 30, 2021 and 2020: Opening balance, December 1, 2019 $ - Recognition upon adoption of IFRS 16 152,864 Lease payments (48,473 ) Interest on lease liability 20,449 Balance, November 30, 2020 $ 124,840 Lease payments (48,175 ) Interest on lease liability 14,760 Cumulative translation adjustment (5,079 ) Balance, November 30, 2021 $ 86,346 Current Portion $ 39,221 Long-term portion $ 47,125 As at November 30, 2021, the minimum lease payments for the lease liabilities are as follows: Year ending: 2022 $ 48,943 2023 50,403 99,346 Less: Interest expense on ease liabilities (13,000 ) Total present value of minimum lease payments $ 86,346 |
BREAKDOWN OF EXPENSES
BREAKDOWN OF EXPENSES | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of attribution of expenses by nature to their function [abstract] | |
BREAKDOWN OF EXPENSES [Text Block] | 17. BREAKDOWN OF EXPENSES General and Administrative Expenses Note 2021 2020 2019 Accounting and audit fees 8 $ 80,162 $ 67,282 $ 80,415 Amortization 5,6,16 143,783 41,201 1,717 Consulting fees 8 456,296 275,182 125,685 General office expenses 205,710 111,394 68,602 Insurance 21,837 11,928 5,416 Interest and accretion 16 14,760 20,449 - Legal fees 191,686 74,528 103,535 Management fees 8 118,000 110,125 125,390 Rent 8 42,822 35,325 77,186 Stock-based compensation 8,12 1,144,342 479,107 692,091 Transfer agent and filing fees 82,825 77,919 111,709 Wages, salaries and benefits 8 817,858 292,218 513,729 Total $ 3,320,081 $ 1,596,658 $ 1,905,475 Research and Development 2021 2020 2019 Labor $ 930,269 $ 386,044 $ 399,720 Materials 54,737 - - Total $ 985,006 $ 386,044 $ 399,720 Selling expenses during the year ended November 30, 2021 consisted of business development expenses amounting to $709,010 (2020 - $1,081,478; 2019 - $739,615). |
SEGMENTED INFORMATION
SEGMENTED INFORMATION | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of operating segments [abstract] | |
SEGMENTED INFORMATION [Text Block] | 18. SEGMENTED INFORMATION The Company operates in one business segment which is focusing on developing technologies as described in Note 1 in the USA and UK. The Company's revenues were generated from operations in the USA and UK with no concentration of customers. All the long-lived assets are located in the U.S. and UK as of November 30, 2021 and 2020. The following table summarizes the revenue and long-lived assets by geographical location: Canada USA UK Total For the year ended November 30, 2021 Revenues $ - $ 79,795 $ 104,601 $ 184,396 Gross Profit - 27,703 53,584 81,287 For the year ended November 30, 2020 Revenues $ - $ 70,931 $ - $ 70,931 Gross Profit - 39,615 - 39,615 For the year ended November 30, 2019 Revenues $ - $ 28,257 $ - $ 28,257 Gross Profit - 16,366 - 16,366 Geographical information relating to the Company's non-current assets (other than financial instruments) is as follows: Canada USA UK Total For the year ended November 30, 2021 Equipment $ - $ 147,395 $ 146,793 $ 294,188 Right of use asset - 72,734 - 72,734 Intangible assets - - 549,679 549,679 For the year ended November 30, 2020 Equipment $ - $ 66,818 $ - $ 66,818 Right of use asset - 114,648 - 114,648 |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Nov. 30, 2021 | |
Income taxes paid (refund) [abstract] | |
INCOME TAXES [Text Block] | 19. INCOME TAXES The following table reconciles the expected income taxes expense (recovery) at the Canadian statutory income tax rates to the amounts recognized in the statement of operations and comprehensive loss for the years ended November 30, 2021 and 2020: 2021 2020 2019 Net loss before tax and comprehensive loss (4,944,231 ) $ (2,924,236 ) $ (4,612,286 ) Combined statutory tax rate 19% to 29.7% 27.00% 27.00% Expected income tax (recovery) $ (1,278,990 ) $ (789,544 ) $ (1,245,317 ) Permanent differences 310,228 - - Non-deductible items and others 19,811 44,866 61,781 Goodwill impairment - - 186,864 Change in estimates - - (214,745 ) Change in deferred tax assets not recognized 948,951 744,678 965,938 Income tax expense (recovery) $ - $ - $ (245,479 ) Significant components of the Company's unrecognized deferred tax assets (liabilities) for the years ended November 30, 2021 and 2020 are shown below: 2021 2020 Non-capital losses $ 2,641,159 $ 1,711,987 Capital losses 21,062 21,062 Equipment 1,511 863 Share issuance costs 29,036 21,843 Intangible assets 397,156 386,345 Others 13,498 12,371 Net deferred tax assets $ 3,103,422 $ 2,154,471 Non-capital losses carryforward: The Company has non-capital loss carryforwards and net operating losses, for which no deferred tax asset has been recognized of approximately $9,703,024 (2020 - $6,111,538) which may be carried forward to apply against future income for Canadian, USA and United Kingdom income tax purposes, subject to the final determination by taxation authorities, expiring in the following years: Expiry 2021 2031 $ 2,937 2032 73,161 2033 59,622 2034 117,154 2035 122,790 2036 138,822 2037 127,413 2038 675,203 2039 2,350,798 2040 2,443,638 2041 3,591,486 TOTAL $ 9,703,024 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of non-adjusting events after reporting period [abstract] | |
SUBSEQUENT EVENTS [Text Block] | 20. SUBSEQUENT EVENTS (a) (b) |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Nov. 30, 2021 | |
Notes to Financial Statements [Abstract] | |
Basis of presentation [Policy Text Block] | Basis of presentation These consolidated financial statements ("Financial Statements") have been prepared in accordance with IFRS as issued by the International Accounting Standard Board ("IASB") and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). These Financial Statements are authorized for issue by the Board of Directors on May 2, 2022. These Financial Statements have been prepared on the historical cost basis. In addition, these Financial Statements have been prepared using the accrual basis of accounting. These Financial Statements are presented in Canadian dollars, which is the Company's functional currency. The functional currency of PRT USA is U.S. Dollars and the functional currency of PRT UK and Tetra is British Pound Sterling ("£"). The assets and liabilities of PRT USA, PRT UK and Tetra are translated into Canadian dollars at the rate of exchange prevailing at the reporting date and their income and expense items are translated at average exchange rates for the period. Exchange differences arising on the translation are recognized in other comprehensive income. |
Significant accounting judgments, estimates and assumptions [Policy Text Block] | Significant accounting judgments, estimates and assumptions The preparation of these Financial Statements in conformity with IFRS requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the Financial Statements and reported amounts of income and expenses during the period. Actual results could differ from these estimates. Significant judgements and estimates used in preparing the Financial Statements include, but are not limited to the following: (i) The calculation of deferred tax is based on the ability of the Company to generate future taxable income, the estimation of which is subject to significant uncertainty as to the amount and timing. The calculation of deferred tax is also based on assumptions, which are subject to uncertainty as to timing and which tax rates are expected to apply when temporary differences reverse. Deferred tax recorded is also subject to uncertainty regarding the magnitude on non-capital losses available for carry forward and of the balances in various tax pools as the corporate tax returns have not been prepared as of the date of financial statement preparation. (ii) The fair value of stock options and finders' warrants issued are subject to the limitations of the Black-Scholes option pricing model that incorporates market data and involves uncertainty in estimates used by management in the assumptions. Because the Black-Scholes option pricing model requires the input of highly subjective assumptions, including the expected lift, volatility of share prices, risk-free rate and dividend yield, changes in subjective input assumptions can materially affect the fair value estimate. (iii) Impairment exists when the carrying value of an asset or cash generating unit ("CGU") exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The fair value less costs to sell calculation is based on available data from binding sales transactions in an arm's length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. The value in use calculation is based on a discounted cash flow model. At November 30, 2019, Management was unable to project cash flows that can be generated from its CGUs and consequently, the intangible assets acquired and the goodwill generated from a previously completed business acquisition were determined to be impaired, therefore an impairment loss of $1,572,552 was charged for the 2019 year end. No impairment loss was recorded during the years ended November 30, 2020 and 2021. Significant judgments used in the preparation of these Financial Statements include, but are not limited to the following: (i) Going concern Management has applied judgements in the assessment of the Company's ability to continue as a going concern when preparing its Financial Statements for the year ended November 30, 2021. Management prepares the Financial Statements on a going concern basis unless management either intends to liquidate the entity or to cease trading or has no realistic alternative but to do so. In assessing whether the going concern assumption is appropriate, management accounts for all available information about the future, which is at least, but is not limited to, 12 months from the end of the reporting period. (ii) Determination of whether a set of assets acquired and liabilities assumed constitute the acquisition of a business or asset may require the Company to make certain judgments as to whether or not the assets acquired and liabilities assumed include the inputs, processes and outputs necessary to constitute a business as defined in IFRS 3 - Business Combinations. Based on an assessment of the relevant facts and circumstances, the Company concluded that the acquisition disclosed in Note 3 was an asset acquisition. (iii) Intangible assets can be capitalized only if development costs can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. To determine if the future economic benefit is probable depends on the successful commercialization of its technologies and that in turn depends on the management's judgement and knowledge. As at November 30, 2021, the Company has customer relationships reported as intangible assets that are being amortized over a period of three years from date of acquisition. |
Cash [Policy Text Block] | Cash Cash consists of amounts held in banks and highly liquid investments with limited interest and credit risk. |
Consolidation [Policy Text Block] | Consolidation The Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances, transactions and any unrealized gains and losses arising from intercompany transactions, have been eliminated. The Company's subsidiaries are presented in the table below. PRT USA was incorporated under the General Corporation Law of the State of Delaware on March 22, 2018. PRT UK was incorporated under the General Corporation Law for England and Wales on March 26, 2021 and Tetra was acquired on June 4, 2021. Entity Country of incorporation Effective economic interest PRT USA United States of America 100% PRT UK United Kingdom 100% Tetra United Kingdom 100% |
Intangible assets [Policy Text Block] | Intangible assets Intangible assets that are reflected in the consolidated statements of financial position consist of assets acquired through business combinations or assets acquisition. Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at their fair value at the acquisition date (which is regarded as their cost). An intangible asset is regarded as having an indefinite useful life when, based on all relevant factors, there is no foreseeable limit to the period over which the asset is expected to generate net cash inflows. Accordingly, the Company does not amortize these intangible assets, but reviews them for impairment, annually or more frequently if events or changes in circumstances indicate that the assets might be impaired. Development costs for internally-generated intangible assets are capitalized when all of the following conditions are met: • technical feasibility can be demonstrated; • management has the intention to complete the intangible asset and use it; • management can demonstrate the ability to use the intangible asset; • it is probable that the intangible asset will generate future economic benefits; • the Company can demonstrate the availability of adequate technical, financial and other resources to complete the development and to use the intangible asset; and • costs attributable to the asset can be measured reliably. The amount initially recognized for internally-generated intangible assets is the sum of the expenditures incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognized, development expenditures are charged to the consolidated statements of loss and comprehensive loss in the period in which they are incurred. Intangible assets with finite life are amortized over the estimated useful lives. |
Equipment [Policy Text Block] | Equipment Recognition and measurement On initial recognition, equipment is valued at cost, being the purchase price and directly attributable cost of acquisition or construction required to bring the asset to the location and condition necessary to be capable of operating in the manner intended by the Company, including appropriate borrowing costs and the estimated present value of any future unavoidable costs of dismantling and removing the items. The corresponding liability is recognized within provisions. Equipment is subsequently measured at cost less accumulated amortization, less any accumulated impairment losses. When parts of an item of equipment have different useful lives, they are accounted for as separate items (major components) of equipment. Gains and losses Gains and losses on disposal of an item of equipment are determined by comparing the proceeds from disposal with the carrying amount and are recognized net within other income in profit or loss. Amortization Half of the normal amortization is taken in the year of acquisition for equipment with declining balance method. The amortization rates applicable to each category of property and equipment are as follows: Computer equipment Furniture Vehicles |
Inventories [Policy Text Block] | Inventories The Company values inventories at the lower of cost and net realizable value. Cost includes the costs of purchases net of vendor allowances plus other costs, such as transportation, that are directly incurred to bring the inventories to their present location and condition. |
Business combinations [Policy Text Block] | Business combinations Business combinations are accounted for using the acquisition method. The cost of the acquisition is measured at the aggregate of the fair values at the date of acquisition, of assets transferred, liabilities incurred or assumed, and equity instruments issued by the Company. The acquiree's identifiable assets and liabilities assumed are recognized at their fair value at the acquisition date. Acquisition related costs are recognized in profit or loss as incurred. The excess of the consideration over the fair value of the net identifiable assets and liabilities acquired is recorded as goodwill. Any gain on a bargain purchase is recorded in profit or loss immediately. Transaction costs are expensed as incurred, except if related to the issue of debt or equity securities. Any goodwill that arises is tested annually for impairment. |
Share capital [Policy Text Block] | Share capital The Company records proceeds from the issuance of its common shares as equity. Proceeds received on the issuance of units, consisting of common shares and warrants are allocated between the common share and warrant component. The Company has adopted a residual value method with respect to the measurement of shares and warrants issued as private placement units. The residual value method first allocates value to the most easily measurable component based on fair value and then the residual value, if any, to the less easily measurable component. The fair value of the common shares issued in the private placement was determined to be the more easily measurable component and were valued at their fair value, as determined by the closing quoted price on the issuance date. The remaining proceeds, if any, are allocated to the attached warrants. Any fair value attributed to the warrants is recorded as warrant reserve. Management does not expect to record a value to the warrant in most equity issuances as unit private placements are commonly priced at market or at a permitted discount to market. If the warrants are issued as share issuance costs, the fair value of agent's warrants are measured using the Black-Scholes option pricing model and recognized in equity as a deduction from the proceeds. If the warrants are exercised, the related amount is reclassified as share capital. If the warrants expire unexercised, the related amount remains in warrant reserve. Incremental costs directly attributable to the issue of new common shares are shown in equity as a deduction, net of tax, from the proceeds. Common shares issued for consideration other than cash are valued based on their market value at the date that shares are issued. |
Stock-based compensation [Policy Text Block] | Stock-based compensation The Company recognizes stock-based compensation expense for the estimated fair value of equity-based instruments granted to both employees and non-employees. Compensation expense is recognized when the options are granted with the same amount being recorded as contributed surplus. The expense is determined using an option pricing model that accounts for the exercise price, the term of the option, the current share price, the expected volatility of the underlying shares, the expected dividend yield, and the risk-free interest rate for the term of the option. If the options are exercised, contributed surplus will be reduced by the applicable amount. Stock-based compensation Share-based payment calculations have no effect in the Company's cash position. |
Earnings (loss) per share [Policy Text Block] | Earnings (loss) per share Basic earnings (loss) per share are calculated using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are calculated using the treasury stock method. This method assumes that common shares are issued for the exercise of options, warrants and convertible securities and that the assumed proceeds from the exercise of options, warrants and convertible securities are used to purchase common shares at the average market price during the period. The difference between the number of shares assumed issued and the number of shares assumed purchased is then added to the basic weighted average number of shares outstanding to determine the fully diluted number of common shares outstanding. No exercise or conversion is assumed during the periods in which a net loss is incurred as the effect is anti-dilutive. |
Financial instruments [Policy Text Block] | Financial instruments Financial assets The Company recognizes financial assets when it becomes party to the contractual provisions of the instrument. Financial assets are measured initially at their fair value plus, in the case of financial assets not subsequently measured at fair value through profit or loss, transaction costs that are directly attributable to their acquisition. Transaction costs attributable to the acquisition of financial assets subsequently measured at fair value through profit or loss are expensed in profit or loss when incurred. Subsequent to initial recognition, all financial assets are classified and subsequently measured at amortized cost. Interest income is calculated using the effective interest method and gains or losses arising from impairment, foreign exchange and derecognition are recognized in profit or loss. Financial assets measured at amortized cost are comprised of cash, accounts receivable and due from related parties. The Company reclassifies debt instruments only when its business model for managing those financial assets has changed. Reclassifications are applied prospectively from the reclassification date and any previously recognized gains, losses or interest are not restated. The Company recognizes a loss allowance for the expected credit losses associated with its financial assets. Expected credit losses are measured to reflect a probability-weighted amount, the time value of money, and reasonable and supportable information regarding past events, current conditions and forecasts of future economic conditions. The Company applies the simplified approach for accounts receivable that do not contain a significant financing component. Using the simplified approach, the Company records a loss allowance equal to the expected credit losses resulting from all possible default events over the assets' contractual lifetime. Financial assets are written off when the Company has no reasonable expectations of recovering all or any portion thereof. The Company derecognizes a financial asset when its contractual rights to the cash flows from the financial asset expire. Financial liabilities The Company recognizes a financial liability when it becomes party to the contractual provisions of the instrument. At initial recognition, the Company measures financial liabilities at their fair value plus transaction costs that are directly attributable to their issuance, with the exception of financial liabilities subsequently measured at fair value through profit or loss for which transaction costs are immediately recorded in profit or loss. Subsequent to initial recognition, all financial liabilities are measured at amortized cost using the effective interest rate method. Interest, gains, and losses relating to a financial liability are recognized in profit or loss. Financial liabilities measured at amortized cost are comprised of accounts payable, lease liability, loans payable and due to related parties. The Company derecognizes a financial liability only when its contractual obligations are discharged, cancelled or expire. Interest Interest income and expense are recognized in profit or loss using the effective interest method. The 'effective interest rate' is the rate that exactly discounts estimated future cash payments over the expected life of the financial instrument to the gross carrying amount of the financial asset or the amortized cost of the financial liability. The effective interest rate is calculated considering all contractual terms of the financial instruments, except for the expected credit losses of financial assets. The 'amortized cost' of a financial asset or financial liability is the amount at which the instrument is measured on initial recognition minus principal repayments, plus or minus any cumulative amortization using the effective interest method of any difference between the initial amount and maturity amount and adjusted for any expected credit loss allowance. The 'gross carrying amount' of a financial asset is the amortized cost of a financial asset before adjusting for any expected credit losses. Interest income and expense is calculated by applying the effective interest rate to the gross carrying amount of the financial asset (when the asset is not credit-impaired) or the amortized cost of the financial liability. Where a financial asset has become credit-impaired subsequent to initial recognition, interest income is calculated in subsequent periods by applying the effective interest method to the amortized cost of the financial asset. If the asset subsequently ceases to be credit-impaired, calculation of interest income reverts to the gross basis. Offsetting Financial assets and financial liabilities are offset, with the net amount presented in the statement of financial position, when, and only when, the Company has a current and legally enforceable right to set off the recognized amounts and intends either to settle on a net basis or realize the asset and settle the liability simultaneously. Income and expenses are presented on a net basis only when permitted under IFRS, or when arising from a group of similar transactions if the resulting income and expenses are not material. |
Revenue recognition [Policy Text Block] | Revenue recognition Revenue is recognized by applying the five-step model under IFRS 15. The Company recognizes revenue when, or as the goods or services are transferred to the control of the customer and performance obligations are satisfied. The Company's revenue is comprised of sales of its radar systems, radar components and engineering design and development services. The Company's revenue is recognized when control of the goods has been transferred, being when the goods are delivered to customers and when all performance obligations have been fulfilled. The amounts recognized as revenue represent the fair values of the considerations received or receivable from third parties on the sales of goods to customers, net of goods and services taxes and less returns, and discounts, at which time there are no conditions for the payment to become due other than the passage of time. For its engineering design and development services, revenue is recognized when the service has been rendered. |
Government Grants [Policy Text Block] | Government Grants Government grants are recognized at fair value once there is reasonable assurance that the Company will comply with the conditions attached to the grants and that the grants will be received. Government grants are recognized in profit or loss on a systematic basis over the periods in which the Company recognizes as expenses the related costs for which the grants are intended to compensate. A forgivable loan from government is treated as a government grant when there is reasonable assurance that the entity will meet the terms for forgiveness of the loan. |
Income taxes [Policy Text Block] | Income taxes Income tax is recognized in profit or loss except to the extent that it relates to equity items, in which case it is recognized in equity. Current tax expense is the expected tax payable on the taxable income for the year, using tax rates enacted at period end, adjusted for amendments to tax payable with regards to previous years. Deferred tax is recorded using the liability method, providing for temporary differences, between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. The following temporary differences do not result in deferred tax assets or liabilities: goodwill not deductible for tax purposes; the initial recognition of assets or liabilities that affect neither accounting profit (loss) nor taxable profit (loss); and differences relating to investments in subsidiaries to the extent that they will probably not reverse in the foreseeable future. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the financial position date. A deferred tax asset is recognized only to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis. |
Related party transactions [Policy Text Block] | Related party transactions Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control and related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. |
Leases [Policy Text Block] | Leases The company adopted IFRS 16 effective December 1, 2019. The Company chose to adopt the modified retrospective approach on transition to IFRS 16 and has chosen not to restate comparative information in accordance with the transitional provisions in IFRS 16. As a result, the comparative information continues to be presented in accordance with the Company's previous accounting policies. The adoption of IFRS 16 resulted in the recognition of a right-of-use asset and a lease liability measured at the present value of the future lease payments on the consolidated statements of financial position. An amortization expense on the right-of-use asset and an interest expense on the lease liability has replaced the operating lease expense. IFRS 16 has changed the presentation of cash flows relating to leases in the Company's consolidated statements of cash flows, however, it does not cause a difference in the amount of cash transferred between the parties of the lease. In accordance with the transition of IFRS 16, the Company recognized a right-of-use asset and lease liability of $152,864 at the adoption date. When measuring lease liabilities, the Company's incremental borrowing rate applied was 15% per annum. |
New IFRS standards that are effective for the current year [Policy Text Block] | New IFRS standards that are effective for the current year In October 2018, the IASB issued "Definition of a Business (Amendments to IFRS 3)". The amendments clarify the definition of a business, with the objective of assisting entities to determine whether a transaction should be accounted for as a business combination or an asset acquisition. The amendments provide an assessment framework to determine when a series of integrated activities is not a business. The amendments are effective for business combinations occurring on or after the beginning of the first annual reporting period beginning on or after January 1, 2020. The Company adopted this amendment on December 1, 2020 and has determined that there has been no material impact to the Company's consolidated financial statements. |
Accounting standards, amendments and interpretations not yet effective [Policy Text Block] | Accounting standards, amendments and interpretations not yet effective Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or the IFRIC during the year but are not yet effective. Some updates that are not applicable or are not consequential to the Company may have been excluded from the list below. IAS 1 - Classification of Liabilities as Current or Noncurrent IAS 16 - Proceeds before Intended Use These new and amended standards are not expected to have a material impact on the Company's consolidated financial statements. |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Significant Accounting Policies [Abstract] | |
Disclosure of subsidiaries [Table Text Block] | Entity Country of incorporation Effective economic interest PRT USA United States of America 100% PRT UK United Kingdom 100% Tetra United Kingdom 100% |
Disclosure of depreciation rates applicable to each category of property and equipment [Table Text Block] | Computer equipment Furniture Vehicles |
ACQUISITION (Tables)
ACQUISITION (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of detailed information about business combination [abstract] | |
Disclosure of purchase price allocation [Table Text Block] | Total Consideration Cash $ 579,682 Net assets acquired (liabilities assumed) Cash indebtedness $ (12,127 ) Equipment 27,799 Prepaid expenses 11,131 Due to a related party (13,699 ) Bank loan (40,447 ) Accounts payable (19,210 ) Vehicle loan (30,859 ) Net assets acquired (liabilities assumed) $ (77,412 ) Purchase price allocation Net identifiable assets acquired $ (77,412 ) Customer relationships 657,094 $ 579,682 |
PREPAID EXPENSES (Tables)
PREPAID EXPENSES (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Detail Information About Prepaid Expenses [Abstract] | |
Disclosure of prepaid expenses [Table Text Block] | November 30, 2021 November 30, 2020 Advertising and promotions $ 127,664 $ 9,494 Rent 11,211 10,993 Other 39,446 5,421 $ 178,321 $ 25,908 |
EQUIPMENT (Tables)
EQUIPMENT (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Property, plant and equipment [abstract] | |
Disclosure of property, plant and equipment [Table Text Block] | Computer Furniture Vehicles Leasehold Demo Total $ $ $ $ $ $ Cost: Balance at November 30, 2019 1,726 12,455 - - - 14,181 Additions - - - - 61,162 61,162 Foreign currency translation adjustment (42 ) (304 ) - - (3,644 ) (3,990 ) Balance at November 30, 2020 1,684 12,151 - - 57,518 71,353 Additions (Note 3) 22,664 7,244 16,243 3,881 184,484 234,516 Foreign currency translation adjustment (320 ) (124 ) (229 ) (55 ) (2,255 ) (2,983 ) Balance at November 30, 2021 24,028 19,271 16,014 3,826 239,747 302,886 Accumulated Depreciation: Balance at November 30, 2019 473 1,244 - - - 1,717 Amortization 702 2,283 - - - 2,985 Foreign currency translation adjustment (41 ) (126 ) - - - (167 ) Balance at November 30, 2020 1,134 3,401 - - - 4,535 Amortization 561 2,055 1,201 287 - 4,104 Foreign currency translation adjustment 21 17 17 4 - 59 Balance at November 30, 2021 1,716 5,473 1,218 291 - 8,698 Net Book Value: At November 30, 2020 550 8,750 - - 57,518 66,818 At November 30, 2021 22,312 13,798 14,796 3,535 239,747 294,188 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Intangible assets and goodwill [abstract] | |
Disclosure of intangible assets [Table Text Block] | Cost: Customer Drone X1 Shoe- Scanner Wi-Ti Total Balance at November 30, 2018 $ - $ 868,547 $ - $ 372,234 $ 1,240,781 Additions - - 30,000 - 30,000 Impairment - (900,260 ) (29,592 ) (385,826 ) (1,315,678 ) Foreign currency translation adjustment - 31,713 (408 ) 13,592 44,897 Balance at November 30, 2019 and 2020 - - - - - Additions 657,094 - - - 657,094 Balance at November 30, 2021 657,094 - - - 657,094 Accumulated amortization: Balance at November 2018, 2019 and 2020 - - - - - - Amortization (107,415 ) - - - (107,415 ) (107,415 ) - - - (107,415 ) Net book value Balance at November 30, 2020 and 2019- - - - - Balance at November 30, 2021 $ 549,679 $ - $ - $ - $ 549,679 |
ACCOUNTS PAYABLE (Tables)
ACCOUNTS PAYABLE (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure Of Detail Information About Accounts Payable [Abstract] | |
Disclosure of accounts payable [Table Text Block] | November 30, 2021 November 30, 2020 Professional fees $ 92,078 $ 74,178 Funds to be returned to investors 43,046 43,046 Advertising costs 42,241 5,164 Due to former shareholder of Tetra 222,771 - Payroll 33,173 - Development costs 123,334 77,675 Others 51,742 42,215 $ 608,385 $ 242,278 |
RELATED PARTY TRANSACTIONS AN_2
RELATED PARTY TRANSACTIONS AND BALANCES (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Related party transactions [abstract] | |
Disclosure of amounts due to directors and officers [Table Text Block] | November 30, 2021 November 30, 2020 Company controlled by Former Chief Financial Officer $ - $ 3,865 Company controlled by Corporate Secretary 10,500 - Chief Executive Officer of the Company 561 823 Director 41,667 41,667 $ 52,728 $ 46,355 |
Disclosure of transactions between related parties [Table Text Block] | November 30, 2021 November 30, 2020 November 30, 2019 Management fees $ 118,000 $ 114,125 $ 123,000 Consulting fees 307,734 166,667 - Accounting fees 36,202 22,852 24,490 Rent 5,000 20,000 - Stock-based compensation 410,132 271,993 260,145 Salaries and benefits to CEO 313,626 133,387 318,790 $ 1,190,694 $ 729,024 $ 726,425 |
Disclosure of management fees explanatory [Table Text Block] | November 30, 2021 November 30, 2020 November 30, 2019 Company controlled by Interim CFO and Corporate Secretary $ 63,000 $ 55,125 $ 63,000 Company controlled by Former CFO 55,000 59,000 60,000 $ 118,000 $ 114,125 $ 123,000 |
Disclosure of information about key management personnel [Table Text Block] | November 30, 2021 November 30, 2020 November 30, 2019 Number of Expense for the Number of Expense for Number of Expense for CEO 600,000 $ 133,275 400,000 $ 44,455 400,000 $ 113,077 Former CFO 150,000 33,319 100,000 11,113 100,000 28,269 Corporate Secretary 150,000 33,319 100,000 11,113 100,000 28,269 Directors 825,000 210,219 1,050,000 205,312 250,000 90,530 1,725,000 $ 410,132 1,650,000 $ 271,993 850,000 $ 260,145 |
LOAN PAYABLE (Tables)
LOAN PAYABLE (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of detailed information about borrowings [abstract] | |
Disclosure of loan payable related to the vehicle acquired [Table Text Block] | Principal Principal Interest Commencement Maturity Balance, 2021 Vehicle £ 13,000 $ 30,859 6.95% May 2, 2019 June 2, 2024 $ 28,877 |
SHARE CAPITAL (Tables)
SHARE CAPITAL (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of classes of share capital [abstract] | |
Disclosure of number and weighted average exercise prices of share options [Table Text Block] | Number of Options Weighted Average Exercise Price Balance, November 30, 2019 3,150,000 $ 0.30 Cancelled (200,000 ) 0.60 Balance, November 30, 2020 2,950,000 0.58 Granted 1,700,000 0.73 Exercised (425,000 ) 0.52 Balance, November 30, 2021 4,225,000 $ 0.65 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [Table Text Block] | Weighted average Weighted Exercise Numbers of options Numbers of options remaining average Expiry Date Price outstanding exercisable life (year) price $ $ January 15, 2024 0.60 2,050,000 2,050,000 1.03 0.29 March 20, 2024 0.60 150,000 150,000 0.08 0.02 November 28, 2024 0.50 325,000 325,000 0.23 0.04 January 21, 2026 0.75 1,550,000 1,550,000 1.52 0.28 June 10, 2026 0.50 150,000 150,000 0.16 0.02 4,225,000 4,225,000 3.02 0.65 |
Disclosure of share purchase warrant transactions [Table Text Block] | Number of Warrants Weighted Average Exercise Price Balance, November 30, 2019 - $ - Warrants granted 7,539,748 0.90 Warrants exercised (1,233,334 ) 0.11 Balance, November 30, 2020 6,306,414 0.23 Warrants granted 9,814,400 0.08 Warrants exercised (6,129,572 ) 0.01 Balance, November 30, 2021 9,991,242 $ 0.41 |
Disclosure of number of share purchase warrants outstanding [Table Text Block] | Expiry Date Exercise Price Number of Warrants Weighted average remaining Weighted average $ $ May 15, 2022 0.20 160,500 0.01 0.00 September 30, 2022 0.50 400,582 0.03 0.02 January 29, 2026 0.25 3,188,160 1.33 0.08 August 9, 2026 0.50 6,242,000 2.93 0.31 9,991,242 4.30 0.41 |
SUPPLEMENTAL CASH FLOW INFORM_2
SUPPLEMENTAL CASH FLOW INFORMATION (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Supplemental Cash Flows Information Abstract | |
Disclosure of supplemental cash flow information [Table Text Block] | November 30, 2021 $ November 30, November 30, Non-cash financing activities: Fair value of options granted and vested 1,144,342 479,107 - Fair value of options exercised 158,106 - 13,590 Fair value of options cancelled and expired - - 59,553 Fair value of warrants granted 174,427 83,109 127,254 Fair value of warrants exercised 36,859 - - Shares issued for finders 100,500 - - Shares issued for options exercised - - 37,500 Shares issued for warrants exercised - - 187,120 Non-cash investing activities: Shares to be issued for acquisition of inventory - - 22,800 Shares issued for consulting services 307,734 125,000 - |
RIGHT-OF-USE ASSETS AND LEASE_2
RIGHT-OF-USE ASSETS AND LEASE LIABILITY (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Right Of Use Assets And Lease Liability [Abstract] | |
Disclosure of continuity of the cost and accumulated amortization of right-of-use assets [Table Text Block] | Opening balance, December 1, 2019 $ - Recognition upon adoption of IFRS 16 152,864 Amortization expense (38,216 ) Balance, November 30, 2020 114,648 Amortization expense (35,654 ) Cumulative translation adjustment (6,260 ) Balance, November 30, 2021 $ 72,734 |
Disclosure of continuity of lease liability [Table Text Block] | Opening balance, December 1, 2019 $ - Recognition upon adoption of IFRS 16 152,864 Lease payments (48,473 ) Interest on lease liability 20,449 Balance, November 30, 2020 $ 124,840 Lease payments (48,175 ) Interest on lease liability 14,760 Cumulative translation adjustment (5,079 ) Balance, November 30, 2021 $ 86,346 Current Portion $ 39,221 Long-term portion $ 47,125 |
Disclosure of minimum lease payments for the lease liabilities [Table Text Block] | Year ending: 2022 $ 48,943 2023 50,403 99,346 Less: Interest expense on ease liabilities (13,000 ) Total present value of minimum lease payments $ 86,346 |
BREAKDOWN OF EXPENSES (Tables)
BREAKDOWN OF EXPENSES (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of attribution of expenses by nature to their function [abstract] | |
Disclosure of breakdown of expenses [Table Text Block] | General and Administrative Expenses Note 2021 2020 2019 Accounting and audit fees 8 $ 80,162 $ 67,282 $ 80,415 Amortization 5,6,16 143,783 41,201 1,717 Consulting fees 8 456,296 275,182 125,685 General office expenses 205,710 111,394 68,602 Insurance 21,837 11,928 5,416 Interest and accretion 16 14,760 20,449 - Legal fees 191,686 74,528 103,535 Management fees 8 118,000 110,125 125,390 Rent 8 42,822 35,325 77,186 Stock-based compensation 8,12 1,144,342 479,107 692,091 Transfer agent and filing fees 82,825 77,919 111,709 Wages, salaries and benefits 8 817,858 292,218 513,729 Total $ 3,320,081 $ 1,596,658 $ 1,905,475 Research and Development 2021 2020 2019 Labor $ 930,269 $ 386,044 $ 399,720 Materials 54,737 - - Total $ 985,006 $ 386,044 $ 399,720 |
SEGMENTED INFORMATION (Tables)
SEGMENTED INFORMATION (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Disclosure of operating segments [abstract] | |
Disclosure of revenue and long-lived assets by geographical location [Table Text Block] | Canada USA UK Total For the year ended November 30, 2021 Revenues $ - $ 79,795 $ 104,601 $ 184,396 Gross Profit - 27,703 53,584 81,287 For the year ended November 30, 2020 Revenues $ - $ 70,931 $ - $ 70,931 Gross Profit - 39,615 - 39,615 For the year ended November 30, 2019 Revenues $ - $ 28,257 $ - $ 28,257 Gross Profit - 16,366 - 16,366 Canada USA UK Total For the year ended November 30, 2021 Equipment $ - $ 147,395 $ 146,793 $ 294,188 Right of use asset - 72,734 - 72,734 Intangible assets - - 549,679 549,679 For the year ended November 30, 2020 Equipment $ - $ 66,818 $ - $ 66,818 Right of use asset - 114,648 - 114,648 |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Nov. 30, 2021 | |
Income taxes paid (refund) [abstract] | |
Disclosure of detailed information about effective income tax expense (recovery) [Table Text Block] | 2021 2020 2019 Net loss before tax and comprehensive loss (4,944,231 ) $ (2,924,236 ) $ (4,612,286 ) Combined statutory tax rate 19% to 29.7% 27.00% 27.00% Expected income tax (recovery) $ (1,278,990 ) $ (789,544 ) $ (1,245,317 ) Permanent differences 310,228 - - Non-deductible items and others 19,811 44,866 61,781 Goodwill impairment - - 186,864 Change in estimates - - (214,745 ) Change in deferred tax assets not recognized 948,951 744,678 965,938 Income tax expense (recovery) $ - $ - $ (245,479 ) |
Disclosure of temporary difference, unused tax losses and unused tax credits [Table Text Block] | 2021 2020 Non-capital losses $ 2,641,159 $ 1,711,987 Capital losses 21,062 21,062 Equipment 1,511 863 Share issuance costs 29,036 21,843 Intangible assets 397,156 386,345 Others 13,498 12,371 Net deferred tax assets $ 3,103,422 $ 2,154,471 |
Disclosure of non-capital loss carryforwards [Table Text Block] | Expiry 2021 2031 $ 2,937 2032 73,161 2033 59,622 2034 117,154 2035 122,790 2036 138,822 2037 127,413 2038 675,203 2039 2,350,798 2040 2,443,638 2041 3,591,486 TOTAL $ 9,703,024 |
NATURE OF OPERATIONS AND ABIL_2
NATURE OF OPERATIONS AND ABILITY TO CONTINUE AS A GOING CONCERN (Narrative) (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Nature Of Operations And Ability To Continue As Going Concern Abstract | |||
Comprehensive loss | $ 4,944,231 | $ 2,904,690 | $ 4,320,563 |
Accumulated deficit | 13,867,962 | 8,893,128 | |
Net cash proceeds pursuant to financing activities | $ 4,417,047 | $ 1,635,564 |
SIGNIFICANT ACCOUNTING POLICI_4
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure Of Significant Accounting Policies [Abstract] | |||
Impairment loss | $ 0 | $ 0 | $ 1,572,552 |
Right-of-use asset and lease liability recognized | $ 152,864 | ||
Incremental borrowing rate | 15.00% |
SIGNIFICANT ACCOUNTING POLICI_5
SIGNIFICANT ACCOUNTING POLICIES - Disclosure of subsidiaries (Details) | 12 Months Ended |
Nov. 30, 2021 | |
PRT USA [Member] | |
Disclosure of subsidiaries [line items] | |
Country of Incorporation | United States of America |
Effective Economic Interest | 100.00% |
PRT UK [Member] | |
Disclosure of subsidiaries [line items] | |
Country of Incorporation | United Kingdom |
Effective Economic Interest | 100.00% |
Tetra [Member] | |
Disclosure of subsidiaries [line items] | |
Country of Incorporation | United Kingdom |
Effective Economic Interest | 100.00% |
SIGNIFICANT ACCOUNTING POLICI_6
SIGNIFICANT ACCOUNTING POLICIES - Disclosure of depreciation rates applicable to each category of property and equipment (Detail) | 12 Months Ended |
Nov. 30, 2021 | |
Computer equipment [Member] | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Depreciation method | declining balance |
Depreciation rates | 55.00% |
Furniture [Member] | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Depreciation method | declining balance |
Depreciation rates | 20.00% |
Leasehold improvement [Member] | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Depreciation method | declining balance |
Depreciation rates | 30.00% |
Demo equipment [Member] | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Depreciation method | declining balance |
Depreciation rates | 20.00% |
Vehicles [Member] | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Depreciation method | declining balance |
Depreciation rates | 30.00% |
ACQUISITION (Narrative) (Detail
ACQUISITION (Narrative) (Details) - Tetra [Member] | Jun. 04, 2021CAD ($) | Jun. 04, 2021GBP (£) |
Disclosure of detailed information about business combination [line items] | ||
Percentage of interest acquired | 100.00% | 100.00% |
Consideration payable | $ 579,682 | £ 350,000 |
Amount (paid) within 7 days [Member] | ||
Disclosure of detailed information about business combination [line items] | ||
Consideration payable | 60,021 | 35,000 |
Amount (paid) within 21 days [Member] | ||
Disclosure of detailed information about business combination [line items] | ||
Consideration payable | 60,479 | 35,000 |
Amount (paid) within 120 days [Member] | ||
Disclosure of detailed information about business combination [line items] | ||
Consideration payable | 236,411 | 140,000 |
Remaining balance [Member] | ||
Disclosure of detailed information about business combination [line items] | ||
Consideration payable | $ 222,771 | £ 140,000 |
ACQUISITION - Disclosure of det
ACQUISITION - Disclosure of detailed information about purchase price allocation (Details) - Jun. 04, 2021 - Tetra [Member] | CAD ($) | GBP (£) |
Disclosure of detailed information about business combination [line items] | ||
Cash | $ 579,682 | |
Net assets acquired (liabilities assumed) | ||
Cash indebtedness | (12,127) | |
Equipment | 27,799 | |
Prepaid expenses | 11,131 | |
Due to a related party | (13,699) | |
Bank loan | (40,447) | |
Accounts payable | (19,210) | |
Vehicle loan | (30,859) | |
Net assets acquired (liabilities assumed) | (77,412) | |
Net identifiable assets acquired | (77,412) | |
Customer relationships | 657,094 | |
Total Consideration | $ 579,682 | £ 350,000 |
PREPAID EXPENSES (Narrative) (D
PREPAID EXPENSES (Narrative) (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Disclosure Of Detail Information About Prepaid Expenses [Abstract] | ||
Prepayment to related parties | $ 5,513 | $ 4,000 |
PREPAID EXPENSES - Disclosure o
PREPAID EXPENSES - Disclosure of prepaid expenses (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Prepaid Expenses [Line Items] | ||
Prepaid expenses | $ 178,321 | $ 25,908 |
Advertising and promotions [Member] | ||
Prepaid Expenses [Line Items] | ||
Prepaid expenses | 127,664 | 9,494 |
Rent [Member] | ||
Prepaid Expenses [Line Items] | ||
Prepaid expenses | 11,211 | 10,993 |
Others [Member] | ||
Prepaid Expenses [Line Items] | ||
Prepaid expenses | $ 39,446 | $ 5,421 |
EQUIPMENT - Disclosure of prope
EQUIPMENT - Disclosure of property, plant and equipment (Details) - CAD ($) | 12 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | $ 66,818 | |
Ending balance | 294,188 | $ 66,818 |
Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 71,353 | 14,181 |
Additions | 234,516 | 61,162 |
Foreign currency translation adjustment | (2,983) | (3,990) |
Ending balance | 302,886 | 71,353 |
Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (4,535) | (1,717) |
Amortization | 4,104 | 2,985 |
Foreign currency translation adjustment | 59 | (167) |
Ending balance | (8,698) | (4,535) |
Computer [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 550 | |
Ending balance | 22,312 | 550 |
Computer [Member] | Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 1,684 | 1,726 |
Additions | 22,664 | 0 |
Foreign currency translation adjustment | (320) | (42) |
Ending balance | 24,028 | 1,684 |
Computer [Member] | Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (1,134) | (473) |
Amortization | 561 | 702 |
Foreign currency translation adjustment | 21 | (41) |
Ending balance | (1,716) | (1,134) |
Furniture [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 8,750 | |
Ending balance | 13,798 | 8,750 |
Furniture [Member] | Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 12,151 | 12,455 |
Additions | 7,244 | 0 |
Foreign currency translation adjustment | (124) | (304) |
Ending balance | 19,271 | 12,151 |
Furniture [Member] | Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (3,401) | (1,244) |
Amortization | 2,055 | 2,283 |
Foreign currency translation adjustment | 17 | (126) |
Ending balance | (5,473) | (3,401) |
Vehicles [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | |
Ending balance | 14,796 | 0 |
Vehicles [Member] | Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Additions | 16,243 | 0 |
Foreign currency translation adjustment | (229) | 0 |
Ending balance | 16,014 | 0 |
Vehicles [Member] | Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 1,201 | 0 |
Foreign currency translation adjustment | 17 | 0 |
Ending balance | (1,218) | 0 |
Leasehold improvement [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | |
Ending balance | 3,535 | 0 |
Leasehold improvement [Member] | Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Additions | 3,881 | 0 |
Foreign currency translation adjustment | (55) | 0 |
Ending balance | 3,826 | 0 |
Leasehold improvement [Member] | Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 287 | 0 |
Foreign currency translation adjustment | 4 | 0 |
Ending balance | (291) | 0 |
Demo equipment [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 57,518 | |
Ending balance | 239,747 | 57,518 |
Demo equipment [Member] | Cost [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 57,518 | 0 |
Additions | 184,484 | 61,162 |
Foreign currency translation adjustment | (2,255) | (3,644) |
Ending balance | 239,747 | 57,518 |
Demo equipment [Member] | Accumulated Depreciation [Member] | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 0 | 0 |
Foreign currency translation adjustment | 0 | 0 |
Ending balance | $ 0 | $ 0 |
INTANGIBLE ASSETS (Narrative) (
INTANGIBLE ASSETS (Narrative) (Details) - CAD ($) | 12 Months Ended | |||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | Nov. 30, 2018 | |
Disclosure of detailed information about intangible assets [line items] | ||||
Intangible assets other than goodwill | $ 549,679 | $ 0 | $ 0 | |
Research and development costs | 985,006 | 386,044 | 399,720 | |
Cost [Member] | ||||
Disclosure of detailed information about intangible assets [line items] | ||||
Intangible assets other than goodwill | 657,094 | 0 | 0 | $ 1,240,781 |
Customer relationship [Member] | ||||
Disclosure of detailed information about intangible assets [line items] | ||||
Intangible assets other than goodwill | $ 549,679 | |||
Estimated useful life | 3 | |||
Customer relationship [Member] | Cost [Member] | ||||
Disclosure of detailed information about intangible assets [line items] | ||||
Intangible assets other than goodwill | $ 657,094 | $ 0 | $ 0 | $ 0 |
INTANGIBLE ASSETS - Disclosure
INTANGIBLE ASSETS - Disclosure of detailed information about Intangible assets (Details) - CAD ($) | 12 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2019 | |
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | $ 0 | |
Ending balance | 549,679 | $ 0 |
Customer relationship [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Ending balance | 549,679 | |
Drone X1 System [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | |
Ending balance | 0 | 0 |
Shoe Scanner [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | |
Ending balance | 0 | 0 |
Wi Ti [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | |
Ending balance | 0 | 0 |
Cost [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 1,240,781 |
Additions | 657,094 | 30,000 |
Impairment | (1,315,678) | |
Foreign currency translation adjustment | 44,897 | |
Ending balance | 657,094 | 0 |
Cost [Member] | Customer relationship [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Additions | 657,094 | 0 |
Impairment | 0 | |
Foreign currency translation adjustment | 0 | |
Ending balance | 657,094 | 0 |
Cost [Member] | Drone X1 System [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 868,547 |
Additions | 0 | 0 |
Impairment | (900,260) | |
Foreign currency translation adjustment | 31,713 | |
Ending balance | 0 | 0 |
Cost [Member] | Shoe Scanner [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Additions | 0 | 30,000 |
Impairment | (29,592) | |
Foreign currency translation adjustment | (408) | |
Ending balance | 0 | 0 |
Cost [Member] | Wi Ti [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 372,234 | |
Additions | 0 | |
Impairment | (385,826) | |
Foreign currency translation adjustment | 13,592 | |
Accumulated amortization [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Amortization | (107,415) | |
Ending balance | (107,415) | 0 |
Accumulated amortization [Member] | Customer relationship [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Amortization | (107,415) | |
Ending balance | (107,415) | 0 |
Accumulated amortization [Member] | Drone X1 System [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 0 | |
Ending balance | 0 | 0 |
Accumulated amortization [Member] | Shoe Scanner [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 0 | |
Ending balance | 0 | 0 |
Accumulated amortization [Member] | Wi Ti [Member] | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 0 | 0 |
Amortization | 0 | |
Ending balance | $ 0 | $ 0 |
ACCOUNTS PAYABLE (Narrative) (D
ACCOUNTS PAYABLE (Narrative) (Details) | 12 Months Ended | ||
Nov. 30, 2021CAD ($) | Nov. 30, 2021GBP (£) | Nov. 30, 2020CAD ($) | |
Disclosure Of Detail Information About Accounts Payable [Abstract] | |||
Acquisition of accounts payable and accrued liabilities | $ 222,771 | £ 140,000 |
ACCOUNTS PAYABLE - Disclosure o
ACCOUNTS PAYABLE - Disclosure of accounts payable (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Trade And Other Payable [Line Items] | ||
Accounts payable | $ 608,385 | $ 242,278 |
Professional fees [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 92,078 | 74,178 |
Funds to be returned to investors [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 43,046 | 43,046 |
Advertising costs [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 42,241 | 5,164 |
Due to former shareholder of Tetra [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 222,771 | 0 |
Payroll [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 33,173 | 0 |
Development costs [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | 123,334 | 77,675 |
Other [Member] | ||
Trade And Other Payable [Line Items] | ||
Accounts payable | $ 51,742 | $ 42,215 |
RELATED PARTY TRANSACTIONS AN_3
RELATED PARTY TRANSACTIONS AND BALANCES (Narrative) (Details) | 12 Months Ended | ||
Nov. 30, 2021CAD ($)share | Nov. 30, 2020CAD ($)share | Nov. 30, 2019CAD ($)share | |
Disclosure of transactions between related parties [line items] | |||
Due from directors and officers | $ 0 | $ 2,500 | |
Due to directors and officers | 52,728 | 46,355 | |
Prepayment to related party | 5,513 | 4,000 | |
Value of common shares issued as compensation for consulting fees | 307,734 | 125,000 | |
Shares issued for consulting services | $ 307,734 | 125,000 | $ 0 |
Number of options granted | share | 1,700,000 | ||
Directors [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Due to directors and officers | $ 41,667 | 41,667 | |
Consulting fees | 307,734 | 166,667 | 0 |
Value of common shares issued as compensation for consulting fees | $ 656,250 | $ 500,000 | $ 0 |
Number of options granted | share | 825,000 | 1,050,000 | 250,000 |
Company controlled by Former Chief Financial Officer [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Due to directors and officers | $ 0 | $ 3,865 | |
Accounting fees | 36,202 | 22,852 | $ 24,490 |
Rent | $ 5,000 | $ 20,000 | $ 0 |
Number of options granted | share | 150,000 | 100,000 | 100,000 |
Related parties [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Accounting fees | $ 36,202 | $ 22,852 | $ 24,490 |
Rent | 5,000 | 20,000 | 0 |
Consulting fees | $ 307,734 | $ 166,667 | $ 0 |
Number of options granted | share | 1,725,000 | 1,650,000 | 850,000 |
RELATED PARTY TRANSACTIONS AN_4
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of amounts due to directors and officers (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Disclosure of transactions between related parties [line items] | ||
Due to directors and officers | $ 52,728 | $ 46,355 |
Company controlled by Former Chief Financial Officer [Member] | ||
Disclosure of transactions between related parties [line items] | ||
Due to directors and officers | 0 | 3,865 |
Company controlled by Interim CFO and Corporate Secretary [Member] | ||
Disclosure of transactions between related parties [line items] | ||
Due to directors and officers | 10,500 | 0 |
Chief Executive Officer of the Company [Member] | ||
Disclosure of transactions between related parties [line items] | ||
Due to directors and officers | 561 | 823 |
Director [Member] | ||
Disclosure of transactions between related parties [line items] | ||
Due to directors and officers | $ 41,667 | $ 41,667 |
RELATED PARTY TRANSACTIONS AN_5
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of transactions between related parties (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure of transactions between related parties [line items] | |||
Stock-based compensation | $ 1,144,342 | $ 479,107 | $ 692,091 |
Related parties [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Management fees | 118,000 | 114,125 | 123,000 |
Consulting fees | 307,734 | 166,667 | 0 |
Accounting fees | 36,202 | 22,852 | 24,490 |
Rent | 5,000 | 20,000 | 0 |
Stock-based compensation | 410,132 | 271,993 | 260,145 |
Salaries and benefits to CEO | 313,626 | 133,387 | 318,790 |
Transactions with related parties | $ 1,190,694 | $ 729,024 | $ 726,425 |
RELATED PARTY TRANSACTIONS AN_6
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about key management personnel (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Company controlled by Interim CFO and Corporate Secretary [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Management fees | $ 63,000 | $ 55,125 | $ 63,000 |
Company controlled by Former CFO [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Management fees | 55,000 | 59,000 | 60,000 |
Related parties [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Management fees | $ 118,000 | $ 114,125 | $ 123,000 |
RELATED PARTY TRANSACTIONS AN_7
RELATED PARTY TRANSACTIONS AND BALANCES - Disclosure of information about options granted to the CEO, CFO, the Corporate Secretary, and the Company's directors (Details) | 12 Months Ended | ||
Nov. 30, 2021CAD ($)share | Nov. 30, 2020CAD ($)share | Nov. 30, 2019CAD ($)share | |
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 1,700,000 | ||
Expense for the period | $ | $ 1,144,342 | $ 479,107 | $ 692,091 |
Related parties [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 1,725,000 | 1,650,000 | 850,000 |
Expense for the period | $ | $ 410,132 | $ 271,993 | $ 260,145 |
CEO [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 600,000 | 400,000 | 400,000 |
Expense for the period | $ | $ 133,275 | $ 44,455 | $ 113,077 |
Former CFO [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 150,000 | 100,000 | 100,000 |
Expense for the period | $ | $ 33,319 | $ 11,113 | $ 28,269 |
Corporate Secretary [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 150,000 | 100,000 | 100,000 |
Expense for the period | $ | $ 33,319 | $ 11,113 | $ 28,269 |
Directors [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Number of options granted | share | 825,000 | 1,050,000 | 250,000 |
Expense for the period | $ | $ 210,219 | $ 205,312 | $ 90,530 |
GOVERMENT ASSISTANCE RECEIVED (
GOVERMENT ASSISTANCE RECEIVED (Narrative) (Details) | 12 Months Ended | ||||
Nov. 30, 2021CAD ($) | Nov. 30, 2020CAD ($) | Nov. 30, 2019CAD ($) | May 04, 2020CAD ($) | May 04, 2020USD ($) | |
Disclosure of detailed information about borrowings [line items] | |||||
Paycheck protection program | $ 0 | $ 100,818 | $ 0 | ||
CARES Act Paycheck Protection Program Loan ("PPP Loan") [Member] | |||||
Disclosure of detailed information about borrowings [line items] | |||||
Loan received | $ 100,818 | $ 75,000 | |||
Borrowings, interest rate | 1.00% | 1.00% | |||
Paycheck protection program | $ 100,818 |
LOAN PAYABLE (Narrative) (Detai
LOAN PAYABLE (Narrative) (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Loans Payable Disclosure [Abstract] | ||
Interest rate increase in default loan payments | 13.90% | |
Loan payable current | $ 6,332 | $ 0 |
LOAN PAYABLE - Disclosure of lo
LOAN PAYABLE - Disclosure of loan payable related to the vehicle acquired (Details) - Tetra Drones Ltd [Member] - Vehicles [Member] | 12 Months Ended | |
Nov. 30, 2021CAD ($) | Nov. 30, 2021GBP (£) | |
Disclosure of detailed information about borrowings [line items] | ||
Principal | $ 30,859 | £ 13,000 |
Interest | 6.95% | 6.95% |
Commencement | May 2, 2019 | |
Maturity | June 2, 2024 | |
Balance as of date | $ 28,877 |
SHARE CAPITAL (Narrative) (Deta
SHARE CAPITAL (Narrative) (Details) | Aug. 09, 2021CAD ($)Yearshare$ / sharesshares | Jun. 10, 2021CAD ($)Yearshare$ / shares | Aug. 13, 2020$ / sharesshares | Jul. 03, 2020$ / sharesshares | May 15, 2020CAD ($)share$ / sharesshares | Feb. 04, 2020CAD ($)share$ / shares | Nov. 12, 2014 | Jan. 29, 2021CAD ($)Yearshare$ / sharesshares | Jan. 21, 2021CAD ($)Yearshare$ / shares | Sep. 30, 2020CAD ($)share$ / sharesshares | Sep. 24, 2020$ / sharesshares | Sep. 22, 2020$ / sharesshares | Aug. 21, 2020CAD ($)shares | Apr. 24, 2020CAD ($)share$ / sharesshares | Nov. 29, 2019CAD ($)Yearshare$ / shares | Mar. 21, 2019CAD ($)Yearshare$ / shares | Jan. 16, 2019CAD ($)Yearshare$ / sharesshares | Apr. 25, 2018 | Nov. 30, 2021CAD ($)share$ / sharesshares | Nov. 30, 2020CAD ($)share$ / sharesshares | Nov. 30, 2019CAD ($)share$ / sharesshares | Nov. 30, 2018shares |
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of shares issued | shares | 483,334 | 500,000 | 50,000 | 100,000 | 100,000 | 425,000 | ||||||||||||||||
Number of share purchase warrants exercised | shares | 483,334 | 500,000 | 50,000 | 100,000 | 100,000 | 6,129,572 | 1,233,334 | 910,300 | ||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.01 | $ 0.11 | |||||||||||||||
Proceeds from warrants exercised | $ | $ 1,332,727 | $ 246,667 | $ 187,120 | |||||||||||||||||||
Number of units issued | shares | 5,750,000 | 3,718,831 | 3,180,000 | 3,128,334 | ||||||||||||||||||
Price per unit issued | 0.4 | 0.15 | 0.2 | 0.15 | ||||||||||||||||||
Proceeds from units issued | $ | $ 2,300,000 | $ 557,825 | $ 636,000 | $ 469,250 | ||||||||||||||||||
Exercise price of warrants granted | $ 0.2 | $ 0.2 | $ 0.08 | $ 0.9 | ||||||||||||||||||
Number of share options exercised | share | 425,000 | 125,000 | ||||||||||||||||||||
Weighted average exercise price, exercised | $ 0.52 | |||||||||||||||||||||
Proceeds from exercise of options | $ | $ 222,500 | |||||||||||||||||||||
Share issue related cost | $ | $ 38,727 | |||||||||||||||||||||
Shares held in escrow | shares | 0 | 607,500 | ||||||||||||||||||||
Number of warrants granted | share | 9,814,400 | 7,539,748 | ||||||||||||||||||||
Percentage of common shares reserved for issuance | 10.00% | |||||||||||||||||||||
Number of stock options granted | share | 1,700,000 | |||||||||||||||||||||
Exercise price of stock options granted | $ 0.73 | |||||||||||||||||||||
Remaining contractual life of stock option | 3 years 7 days | |||||||||||||||||||||
Number of options cancelled | share | 200,000 | 150,000 | ||||||||||||||||||||
Stock-based compensation recognized in profit or loss | $ | $ 1,144,342 | $ 479,107 | $ 692,091 | |||||||||||||||||||
Amount of compensation share based payment vested | $ | 67,665 | |||||||||||||||||||||
Value of common shares issued as compensation for consulting fees | $ | $ 307,734 | 125,000 | ||||||||||||||||||||
Bottom of range [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Weighted average exercise price, exercised | $ 0.5 | |||||||||||||||||||||
Top of range [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Weighted average exercise price, exercised | $ 0.6 | |||||||||||||||||||||
Share capital [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Proceeds from warrants exercised | $ | $ 1,332,727 | 246,667 | $ 187,120 | |||||||||||||||||||
Share issue related cost | $ | $ 38,727 | |||||||||||||||||||||
Number of shares issued and outstanding | shares | 59,239,336 | 42,762,264 | 32,796,600 | 31,761,300 | ||||||||||||||||||
Common shares issued as compensation for consulting fees | shares | 656,250 | 500,000 | ||||||||||||||||||||
Value of common shares issued as compensation for consulting fees | $ | $ 307,734 | $ 125,000 | ||||||||||||||||||||
Aerowave Corporation ("Aerowave") [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of units issued | shares | 50,000 | |||||||||||||||||||||
Proceeds from units issued | $ | $ 22,811 | |||||||||||||||||||||
Exercise price of warrants granted | $ 0.5 | |||||||||||||||||||||
Warrants granted, estimated fair value | $ | $ 1,500 | |||||||||||||||||||||
Warrants granted, exercisable period | 2 years | |||||||||||||||||||||
Directors Officers Employee And Consultants [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 1,550,000 | 2,300,000 | ||||||||||||||||||||
Exercise price of stock options granted | $ 0.75 | $ 0.6 | ||||||||||||||||||||
Remaining contractual life of stock option | 5 years | 5 years | ||||||||||||||||||||
Number of options cancelled | share | 150,000 | |||||||||||||||||||||
Number of remaining share options granted in share based payment arrangement | shares | 2,150,000 | |||||||||||||||||||||
Stock price | $ 0.75 | $ 0.54 | ||||||||||||||||||||
Volatility | 100.00% | 100.00% | ||||||||||||||||||||
Risk-free rate | 0.43% | 1.93% | ||||||||||||||||||||
Dividend yield | 0.00% | 0.00% | ||||||||||||||||||||
Expected life | Year | 5 | 5 | ||||||||||||||||||||
Fair value of stock option | $ | $ 1,022,995 | $ 913,140 | ||||||||||||||||||||
Consultant [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 150,000 | 350,000 | ||||||||||||||||||||
Exercise price of stock options granted | $ 0.5 | $ 0.6 | ||||||||||||||||||||
Remaining contractual life of stock option | 5 years | 5 years | ||||||||||||||||||||
Stock price | $ 0.485 | $ 0.57 | ||||||||||||||||||||
Volatility | 100.00% | 100.00% | ||||||||||||||||||||
Risk-free rate | 0.82% | 1.56% | ||||||||||||||||||||
Dividend yield | 0.00% | 0.00% | ||||||||||||||||||||
Expected life | Year | 5 | 5 | ||||||||||||||||||||
Fair value of stock option | $ | $ 53,682 | $ 147,613 | ||||||||||||||||||||
Consultant And Director [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 650,000 | |||||||||||||||||||||
Exercise price of stock options granted | $ 0.5 | |||||||||||||||||||||
Remaining contractual life of stock option | 5 years | |||||||||||||||||||||
Stock price | $ 0.49 | |||||||||||||||||||||
Volatility | 100.00% | |||||||||||||||||||||
Risk-free rate | 1.49% | |||||||||||||||||||||
Dividend yield | 0.00% | |||||||||||||||||||||
Expected life | Year | 5 | |||||||||||||||||||||
Fair value of stock option | $ | $ 236,809 | |||||||||||||||||||||
Director [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Common shares issued as compensation for consulting fees | shares | 250,000 | 250,000 | 656,250 | |||||||||||||||||||
Value of common shares issued as compensation for consulting fees | $ | $ 62,500 | $ 62,500 | $ 307,734 | |||||||||||||||||||
Exercise Price 0.60 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of share purchase warrants exercised | shares | 7,500 | |||||||||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.6 | |||||||||||||||||||||
Exercise Price 0.40 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of share purchase warrants exercised | shares | 307,800 | |||||||||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.4 | |||||||||||||||||||||
Exercise Price 0.10 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of share purchase warrants exercised | shares | 595,000 | |||||||||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.1 | |||||||||||||||||||||
Exercise Price 0.30 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of share options exercised | share | 125,000 | |||||||||||||||||||||
Weighted average exercise price, exercised | $ 0.3 | |||||||||||||||||||||
Proceeds from exercise of options | $ | $ 37,500 | |||||||||||||||||||||
Private Placements [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Exercise price of warrants granted | $ 0.5 | $ 0.5 | ||||||||||||||||||||
Share issue related cost | $ | $ 38,727 | $ 38,727 | ||||||||||||||||||||
Number of warrants granted | share | 325,750 | 222,400 | ||||||||||||||||||||
Stock price | $ 0.35 | $ 0.52 | ||||||||||||||||||||
Volatility | 100.00% | 100.00% | ||||||||||||||||||||
Risk-free rate | 0.88% | 0.43% | ||||||||||||||||||||
Dividend yield | 0.00% | 0.00% | ||||||||||||||||||||
Expected life | Year | 5 | 5 | ||||||||||||||||||||
Fair value of stock option | $ | $ 79,032 | $ 95,395 | ||||||||||||||||||||
Finder's Fees [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Exercise price of warrants granted | $ 0.5 | $ 0.25 | ||||||||||||||||||||
Shares issued for finder's fees, shares | shares | 166,250 | 170,000 | ||||||||||||||||||||
Shares issued for finder's fees, value | $ | $ 63,700 | $ 10,480 | ||||||||||||||||||||
Fair value of finders units issued | $ | $ 66,500 | $ 34,000 | ||||||||||||||||||||
Warrants granted, exercisable period | 5 years | 5 years | ||||||||||||||||||||
Non-brokered private placement financing [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of units issued for private placement | share | 10,000,000 | |||||||||||||||||||||
Price per unit issued | 0.4 | |||||||||||||||||||||
Proceeds from units issued | $ | $ 4,000,000 | |||||||||||||||||||||
Exercise price of warrants granted | $ 0.2 | $ 0.8 | $ 0.5 | $ 0.2 | ||||||||||||||||||
Number of warrants granted | share | 3,718,831 | 692,583 | 3,128,334 | |||||||||||||||||||
Cancelled private placement, amount held | $ | $ 4,400 | |||||||||||||||||||||
Share Purchase Warrant [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of shares issued | shares | 6,129,572 | |||||||||||||||||||||
Number of share purchase warrants exercised | shares | 6,129,572 | |||||||||||||||||||||
Proceeds from warrants exercised | $ | $ 1,332,727 | |||||||||||||||||||||
Number of units issued | shares | 1,335,165 | |||||||||||||||||||||
Price per unit issued | 0.3 | |||||||||||||||||||||
Proceeds from units issued | $ | $ 400,550 | |||||||||||||||||||||
Exercise price of warrants granted | $ 0.5 | $ 0.25 | $ 0.5 | |||||||||||||||||||
Warrants granted, estimated fair value | $ | $ 40,055 | |||||||||||||||||||||
Warrants granted, exercisable period | 5 years | 5 years | 2 years | |||||||||||||||||||
Number of warrants granted | share | 5,916,250 | 3,350,000 | ||||||||||||||||||||
Share Purchase Warrant [Member] | Bottom of range [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.2 | |||||||||||||||||||||
Share Purchase Warrant [Member] | Top of range [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Weighted average exercise price of warrants exercised | $ 0.5 | |||||||||||||||||||||
Broker Warrants [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Exercise price of warrants granted | $ 0.5 | $ 0.25 | ||||||||||||||||||||
Shares issued for finder's fees, shares | shares | 325,750 | 222,400 | ||||||||||||||||||||
Warrants granted, exercisable period | 5 years | 5 years | ||||||||||||||||||||
Options Vesting January 15, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 1,075,000 | |||||||||||||||||||||
Options Vesting April 15, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 268,750 | |||||||||||||||||||||
Options Vesting July 15, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 268,750 | |||||||||||||||||||||
Options Vesting October 15, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 268,750 | |||||||||||||||||||||
Options Vesting January 15, 2021 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 268,750 | |||||||||||||||||||||
Options Vesting March 20, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 175,000 | |||||||||||||||||||||
Options Vesting June 20, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 43,750 | |||||||||||||||||||||
Options Vesting December 20, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 43,750 | |||||||||||||||||||||
Options Vesting March 20, 2021 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 43,750 | |||||||||||||||||||||
Options Vesting June 20, 2021 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 43,750 | |||||||||||||||||||||
Options Vesting November 30, 2020 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 325,000 | |||||||||||||||||||||
Options Vesting November 30, 2021 [Member] | ||||||||||||||||||||||
Disclosure of classes of share capital [line items] | ||||||||||||||||||||||
Number of stock options granted | share | 325,000 |
SHARE CAPITAL - Disclosure of n
SHARE CAPITAL - Disclosure of number and weighted average exercise prices of share options (Details) | 12 Months Ended | ||
Nov. 30, 2021share$ / shares | Nov. 30, 2020share$ / shares | Nov. 30, 2019share$ / shares | |
Disclosure of classes of share capital [abstract] | |||
Number of options outstanding, beginning balance | share | 2,950,000 | 3,150,000 | |
Weighted average exercise price, beginning balance | $ / shares | $ 0.58 | $ 0.3 | |
Number of options granted | share | 1,700,000 | ||
Exercise price of stock options granted | $ / shares | $ 0.73 | ||
Number of options exercised | share | (425,000) | (125,000) | |
Weighted average exercise price, exercised | $ / shares | $ 0.52 | ||
Number of options cancelled | share | (200,000) | (150,000) | |
Weighted average exercise price, cancelled | $ / shares | $ 0.6 | ||
Number of options outstanding, ending balance | share | 4,225,000 | 2,950,000 | 3,150,000 |
Weighted average exercise price, ending balance | $ / shares | $ 0.65 | $ 0.58 | $ 0.3 |
SHARE CAPITAL - Disclosure of_2
SHARE CAPITAL - Disclosure of number and weighted average remaining contractual life of outstanding share options (Details) | 12 Months Ended | ||
Nov. 30, 2021share$ / shares | Nov. 30, 2020share | Nov. 30, 2019share | |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Numbers of options outstanding | 4,225,000 | 2,950,000 | 3,150,000 |
Numbers of options exercisable | 4,225,000 | ||
Weighted average remaining contractual life (year) | 3 years 7 days | ||
Weighted average exercise price | $ / shares | $ 0.65 | ||
January 15, 2024 [Member] | Exercise Price 0.60 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ / shares | $ 0.6 | ||
Numbers of options outstanding | 2,050,000 | ||
Numbers of options exercisable | 2,050,000 | ||
Weighted average remaining contractual life (year) | 1 year 10 days | ||
Weighted average exercise price | $ / shares | $ 0.29 | ||
March 20, 2024 [Member] | Exercise Price 0.60 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ / shares | $ 0.6 | ||
Numbers of options outstanding | 150,000 | ||
Numbers of options exercisable | 150,000 | ||
Weighted average remaining contractual life (year) | 29 days | ||
Weighted average exercise price | $ / shares | $ 0.02 | ||
November 28, 2024 [Member] | Exercise Price 0.50 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ / shares | $ 0.5 | ||
Numbers of options outstanding | 325,000 | ||
Numbers of options exercisable | 325,000 | ||
Weighted average remaining contractual life (year) | 2 months 23 days | ||
Weighted average exercise price | $ / shares | $ 0.04 | ||
January 21, 2026 [Member] | Exercise Price 0.75 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ / shares | $ 0.75 | ||
Numbers of options outstanding | 1,550,000 | ||
Numbers of options exercisable | 1,550,000 | ||
Weighted average remaining contractual life (year) | 1 year 6 months 7 days | ||
Weighted average exercise price | $ / shares | $ 0.28 | ||
June 10, 2026 [Member] | Exercise Price 0.50 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ / shares | $ 0.5 | ||
Numbers of options outstanding | 150,000 | ||
Numbers of options exercisable | 150,000 | ||
Weighted average remaining contractual life (year) | 1 month 28 days | ||
Weighted average exercise price | $ / shares | $ 0.02 |
SHARE CAPITAL - Disclosure of s
SHARE CAPITAL - Disclosure of share purchase warrant transactions (Details) | Aug. 13, 2020$ / sharesshares | Jul. 03, 2020$ / sharesshares | May 15, 2020$ / shares | Sep. 30, 2020$ / sharesshares | Sep. 24, 2020$ / sharesshares | Sep. 22, 2020$ / sharesshares | Apr. 24, 2020$ / shares | Nov. 30, 2021share$ / sharesshares | Nov. 30, 2020share$ / sharesshares | Nov. 30, 2019share$ / sharesshares |
Disclosure of classes of share capital [abstract] | ||||||||||
Warrants outstanding, beginning balance | share | 6,306,414 | 0 | ||||||||
Weighted average exercise price, beginning balance | $ 0.23 | $ 0 | ||||||||
Warrants granted | share | 9,814,400 | 7,539,748 | ||||||||
Weighted average exercise price of warrants granted | $ 0.2 | $ 0.2 | $ 0.08 | $ 0.9 | ||||||
Warrants exercised | shares | (483,334) | (500,000) | (50,000) | (100,000) | (100,000) | (6,129,572) | (1,233,334) | (910,300) | ||
Weighted average exercise price of warrants exercised | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.01 | $ 0.11 | |||
Warrants outstanding, ending balance | share | 9,991,242 | 6,306,414 | 0 | |||||||
Weighted average exercise price, ending balance | $ 0.41 | $ 0.23 | $ 0 |
SHARE CAPITAL - Disclosure of_3
SHARE CAPITAL - Disclosure of number of share purchase warrants outstanding (Details) | 12 Months Ended | ||
Nov. 30, 2021share$ / shares | Nov. 30, 2020share$ / shares | Nov. 30, 2019share$ / shares | |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Numbers of warrants outstanding | share | 9,991,242 | 6,306,414 | 0 |
Weighted average remaining contractual life (year) | 4 years 3 months 18 days | ||
Weighted average exercise price | $ 0.41 | $ 0.23 | $ 0 |
May 15, 2022 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ 0.2 | ||
Numbers of warrants outstanding | share | 160,500 | ||
Weighted average remaining contractual life (year) | 3 days | ||
Weighted average exercise price | $ 0 | ||
September 30, 2022 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ 0.5 | ||
Numbers of warrants outstanding | share | 400,582 | ||
Weighted average remaining contractual life (year) | 10 days | ||
Weighted average exercise price | $ 0.02 | ||
January 29, 2026 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ 0.25 | ||
Numbers of warrants outstanding | share | 3,188,160 | ||
Weighted average remaining contractual life (year) | 1 year 3 months 29 days | ||
Weighted average exercise price | $ 0.08 | ||
August 9, 2026 [Member] | |||
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] | |||
Exercise Price | $ 0.5 | ||
Numbers of warrants outstanding | share | 6,242,000 | ||
Weighted average remaining contractual life (year) | 2 years 11 months 4 days | ||
Weighted average exercise price | $ 0.31 |
FINANCIAL RISK MANAGEMENT (Narr
FINANCIAL RISK MANAGEMENT (Narrative) (Details) - Foreign Currency Risk [Member] - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure of nature and extent of risks arising from financial instruments [line items] | |||
Potential fluctuations in functional currency exchange rate | 10.00% | ||
Comprehensive loss due to fluctuations in US dollar against the Canadian dollar | $ 1,200 | $ 7,085 | $ 1,100 |
SUPPLEMENTAL CASH FLOW INFORM_3
SUPPLEMENTAL CASH FLOW INFORMATION - Disclosure of supplemental cash flow information (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Non-cash financing activities | |||
Fair value of options granted and vested | $ 1,144,342 | $ 479,107 | $ 0 |
Fair value of options exercised | 158,106 | 0 | 13,590 |
Fair value of options cancelled and expired | 0 | 0 | 59,553 |
Fair value of warrants granted | 174,427 | 83,109 | 127,254 |
Fair value of warrants exercised | 36,859 | 0 | 0 |
Shares issued for finders | 100,500 | 0 | 0 |
Shares issued for options exercised | 0 | 0 | 37,500 |
Shares issued for warrants exercised | 0 | 0 | 187,120 |
Non-cash investing activities: | |||
Shares to be issued for acquisition of inventory | 0 | 0 | 22,800 |
Shares issued for consulting services | $ 307,734 | $ 125,000 | $ 0 |
COMMITMENTS (Narrative) (Detail
COMMITMENTS (Narrative) (Details) | Apr. 01, 2020CAD ($) | Oct. 31, 2021CAD ($) | Nov. 30, 2018 | Nov. 30, 2021CAD ($) | Nov. 30, 2021GBP (£) | Nov. 30, 2021USD ($) |
Disclosure Of Commitments [Line Items] | ||||||
Key management compensation | $ 35,875 | |||||
PRT UK [Member] | License Fee Agreement [Member] | ||||||
Disclosure Of Commitments [Line Items] | ||||||
license fee | £ | £ 1,500 | |||||
PRT USA [Member] | ||||||
Disclosure Of Commitments [Line Items] | ||||||
Monthly lease payment | $ 1,500 | |||||
Term of lease | 2 years | |||||
Monthly lease payment, next twelve months | 3,188 | |||||
Monthly lease payment, year two | $ 3,284 | |||||
Director [Member] | ||||||
Disclosure Of Commitments [Line Items] | ||||||
Consulting fees | $ 250,000 | |||||
Unrelated party [Member] | Consulting Agreement [Member] | ||||||
Disclosure Of Commitments [Line Items] | ||||||
Consulting fees | $ 90,000 |
RIGHT-OF-USE ASSETS AND LEASE_3
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of the cost and accumulated amortization of right-of-use assets (Details) - CAD ($) | 12 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
Right Of Use Assets And Lease Liability [Abstract] | ||
Opening balance | $ 114,648 | $ 0 |
Recognition upon adoption of IFRS 16 | 152,864 | |
Amortization expense | (35,654) | (38,216) |
Cumulative translation adjustment | (6,260) | |
Closing balance | $ 72,734 | $ 114,648 |
RIGHT-OF-USE ASSETS AND LEASE_4
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of continuity of lease liability (Details) - CAD ($) | 12 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
Right Of Use Assets And Lease Liability [Abstract] | ||
Opening balance | $ 124,840 | $ 0 |
Recognition upon adoption of IFRS 16 | 152,864 | |
Lease payment | (48,175) | (48,473) |
Interest on lease liability | 14,760 | 20,449 |
Cumulative translation adjustment | (5,079) | |
Closing balance | 86,346 | 124,840 |
Current portion | 39,221 | 34,105 |
Long-term portion | $ 47,125 | $ 90,735 |
RIGHT-OF-USE ASSETS AND LEASE_5
RIGHT-OF-USE ASSETS AND LEASE LIABILITY - Disclosure of minimum lease payments for the lease liabilities (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 |
Disclosure of maturity analysis of operating lease payments [line items] | |||
Minimum lease payments for lease liabilities | $ 99,346 | ||
Less: Interest expense on lease liabilities | (13,000) | ||
Total present value of minimum lease payments | 86,346 | $ 124,840 | $ 0 |
2022 [Member] | |||
Disclosure of maturity analysis of operating lease payments [line items] | |||
Minimum lease payments for lease liabilities | 48,943 | ||
2023 [Member] | |||
Disclosure of maturity analysis of operating lease payments [line items] | |||
Minimum lease payments for lease liabilities | $ 50,403 |
BREAKDOWN OF EXPENSES (Narrativ
BREAKDOWN OF EXPENSES (Narrative) (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure of attribution of expenses by nature to their function [abstract] | |||
Selling expenses | $ 709,010 | $ 1,081,478 | $ 739,615 |
BREAKDOWN OF EXPENSES - Disclos
BREAKDOWN OF EXPENSES - Disclosure of breakdown of expenses (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure of attribution of expenses by nature to their function [line items] | |||
Interest and accretion | $ 14,760 | $ 20,449 | |
Stock-based compensation | 1,144,342 | 479,107 | $ 692,091 |
Total | 3,320,081 | 1,596,658 | 1,905,475 |
Total | 985,006 | 386,044 | 399,720 |
General and Administrative Expenses [Member] | |||
Disclosure of attribution of expenses by nature to their function [line items] | |||
Accounting and audit fees | 80,162 | 67,282 | 80,415 |
Amortization | 143,783 | 41,201 | 1,717 |
Consulting fees | 456,296 | 275,182 | 125,685 |
General office expenses | 205,710 | 111,394 | 68,602 |
Insurance | 21,837 | 11,928 | 5,416 |
Interest and accretion | 14,760 | 20,449 | 0 |
Legal fees | 191,686 | 74,528 | 103,535 |
Management fees | 118,000 | 110,125 | 125,390 |
Rent | 42,822 | 35,325 | 77,186 |
Stock-based compensation | 1,144,342 | 479,107 | 692,091 |
Transfer agent and filing fees | 82,825 | 77,919 | 111,709 |
Wages, salaries and benefits | 817,858 | 292,218 | 513,729 |
Total | 3,320,081 | 1,596,658 | 1,905,475 |
Research and Development [Member] | |||
Disclosure of attribution of expenses by nature to their function [line items] | |||
Labor | 930,269 | 386,044 | 399,720 |
Materials | 54,737 | 0 | 0 |
Total | $ 985,006 | $ 386,044 | $ 399,720 |
SEGMENTED INFORMATION - Disclos
SEGMENTED INFORMATION - Disclosure of revenue by geographical location (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure of operating segments [line items] | |||
Sales | $ 184,396 | $ 70,931 | $ 28,257 |
Gross Profit | 81,287 | 39,615 | 16,366 |
Canada [Member] | |||
Disclosure of operating segments [line items] | |||
Sales | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 |
USA [Member] | |||
Disclosure of operating segments [line items] | |||
Sales | 79,795 | 70,931 | 28,257 |
Gross Profit | 27,703 | 39,615 | 16,366 |
UK [Member] | |||
Disclosure of operating segments [line items] | |||
Sales | 104,601 | 0 | 0 |
Gross Profit | $ 53,584 | $ 0 | $ 0 |
SEGMENTED INFORMATION - Discl_2
SEGMENTED INFORMATION - Disclosure of long-lived assets by geographical location (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 |
Disclosure of operating segments [line items] | |||
Equipment | $ 294,188 | $ 66,818 | |
Right of use asset | 72,734 | 114,648 | $ 0 |
Intangible assets | 549,679 | 0 | $ 0 |
Canada [Member] | |||
Disclosure of operating segments [line items] | |||
Equipment | 0 | 0 | |
Right of use asset | 0 | 0 | |
Intangible assets | 0 | ||
USA [Member] | |||
Disclosure of operating segments [line items] | |||
Equipment | 147,395 | 66,818 | |
Right of use asset | 72,734 | 114,648 | |
Intangible assets | 0 | ||
UK [Member] | |||
Disclosure of operating segments [line items] | |||
Equipment | 146,793 | 0 | |
Right of use asset | 0 | $ 0 | |
Intangible assets | $ 549,679 |
INCOME TAXES (Narrative) (Detai
INCOME TAXES (Narrative) (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Income taxes paid (refund) [abstract] | ||
Non-capital losses carryforwards | $ 9,703,024 | $ 6,111,538 |
INCOME TAXES - Disclosure of de
INCOME TAXES - Disclosure of detailed information about effective income tax expense (recovery) (Details) - CAD ($) | 12 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2019 | |
Disclosure Of Income Taxes [Line Items] | |||
Net loss before tax and comprehensive loss | $ (4,944,231) | $ (2,924,236) | $ (4,612,286) |
Combined statutory tax rate | 27.00% | 27.00% | |
Expected income tax (recovery) | (1,278,990) | $ (789,544) | $ (1,245,317) |
Permanent differences | 310,228 | 0 | 0 |
Non-deductible items and others | 19,811 | 44,866 | 61,781 |
Goodwill impairment | 0 | 0 | 186,864 |
Change in estimates | 0 | 0 | (214,745) |
Change in deferred tax assets not recognized | 948,951 | 744,678 | 965,938 |
Income tax expense (recovery) | $ 0 | $ 0 | $ (245,479) |
Bottom of range [Member] | |||
Disclosure Of Income Taxes [Line Items] | |||
Combined statutory tax rate | 19.00% | ||
Top of range [Member] | |||
Disclosure Of Income Taxes [Line Items] | |||
Combined statutory tax rate | 29.70% |
INCOME TAXES - Disclosure of te
INCOME TAXES - Disclosure of temporary difference, unused tax losses and unused tax credits (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Income taxes paid (refund) [abstract] | ||
Non-capital loss | $ 2,641,159 | $ 1,711,987 |
Capital losses | 21,062 | 21,062 |
Equipment | 1,511 | 863 |
Share issuance costs | 29,036 | 21,843 |
Intangible assets | 397,156 | 386,345 |
Others | 13,498 | 12,371 |
Net deferred tax assets | $ 3,103,422 | $ 2,154,471 |
INCOME TAXES - Disclosure of no
INCOME TAXES - Disclosure of non-capital loss carryforwards (Details) - CAD ($) | Nov. 30, 2021 | Nov. 30, 2020 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | $ 9,703,024 | $ 6,111,538 |
2031 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 2,937 | |
2032 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 73,161 | |
2033 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 59,622 | |
2034 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 117,154 | |
2035 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 122,790 | |
2036 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 138,822 | |
2037 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 127,413 | |
2038 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 675,203 | |
2039 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 2,350,798 | |
2040 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | 2,443,638 | |
2041 [Member] | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Non-capital losses carryforwards | $ 3,591,486 |
SUBSEQUENT EVENTS (Narrative) (
SUBSEQUENT EVENTS (Narrative) (Details) | Aug. 13, 2020$ / shares | Jul. 03, 2020$ / shares | Feb. 28, 2022share$ / shares | Dec. 31, 2021CAD ($)shares | Sep. 30, 2020$ / shares | Sep. 24, 2020$ / shares | Sep. 22, 2020$ / shares | Nov. 30, 2021share$ / shares | Nov. 30, 2020$ / shares | Nov. 30, 2019share |
Disclosure of non-adjusting events after reporting period [line items] | ||||||||||
Weighted average exercise price of warrants exercised | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.2 | $ 0.01 | $ 0.11 | |||
Number of share options exercised | share | 425,000 | 125,000 | ||||||||
Exercise price of stock options exercised | $ 0.52 | |||||||||
Consultant And Director [Member] | ||||||||||
Disclosure of non-adjusting events after reporting period [line items] | ||||||||||
Number of shares issued | shares | 78,125 | |||||||||
Professional fees expense | $ | $ 17,188 | |||||||||
Subsequent Events [Member] | ||||||||||
Disclosure of non-adjusting events after reporting period [line items] | ||||||||||
Number of share options exercised | share | 125,000 | |||||||||
Exercise price of stock options exercised | $ 0.5 |